+0.80 [social_text] “gets to $1400 in 2035!” — The author's bullish thesis is that MRNA's value will reach $1,400 by 2035.
stocktwits

+0.80 [social_text] “$2.4B Mcap is about to be a $24B Mcap and Climbing. Any Day Now.” — This is a strongly bullish attributed market-cap forecast for MRNA.
stocktwits

+0.80 [social_text] “this is going to $300 in Oct” — The post is an explicit bullish forward price target for Moderna.
stocktwits

+0.60 [social_text] “Target Zone: $23.24 – $28.40” — The contract specifies a bullish option target range for MRNA.
stocktwits

+0.00 [social_text] “buy the one that’s not expensive” — The post is a generic price-based recommendation without a company-specific fundamental or attributed opinion.
stocktwits

-0.60 [social_text] “Most expensive stock in big pharma” — The item asserts MRNA is the most expensive biopharma stock, a negative valuation observation.
stocktwits

-0.60 [social_text] “Most of the bears here will disappear by EOW” — The attributed bearish view is presented as a forward-looking opinion that bears will disappear.
stocktwits

+0.70 [social_text] “$210 by Friday” — The named target is an explicitly bullish forward price opinion.
stocktwits

+0.00 [social_text] “$MRNA 1% down” — The item reports only a small share-price move without a stated fundamental reason.
stocktwits

+0.00 [social_text] “Thursday Trade Plan from the team: $MRVL 270C above 267, $MRNA 200C above 197.44, $HOOD 110P below 112.57, $MSFT 515C above 513.50. Each one is a trigger level for tomorrow's session, with the chart for each attached.” — The item presents technical trading levels for multiple companies, including MRNA, without a substantive directional opinion on Moderna itself.
stocktwits

+0.00 [social_text] “$MRNA loaded up again” — The item reports MRNA's share-price movement without a scorable fundamental reason.
stocktwits

+0.60 [social_text] “bastard pumpers trying to get other inexperienced retail traders to buy into this stock, knowing its overpriced and due for a crash back to 130” — The author advances a bearish thesis that the stock is overpriced and due to crash, which is a negative attributed opinion.
stocktwits

+0.00 [social_text] “this is just straight up ignored” — The post observes that MRNA is being ignored, which is a neutral company-specific observation without a directional fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA $120?” — The item is a bare price question with no stated fundamental or attributed opinion.
stocktwits

-0.70 [social_text] “the company that cures cancer is worth 80 a share” — The attributed Citi valuation is a strongly negative forward opinion on MRNA.
stocktwits

+0.00 [social_text] “$MRNA $120?” — The item is a price-level question with no stated fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “That’s where the real activity begins” — The item describes when trading activity occurs without stating a substantive MRNA proposition.
stocktwits

-0.40 [social_text] “Load more short” — The post indicates elevated short interest in Moderna, a bearish attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA tried to warn you.” — The item is a bare investor observation about MRNA without a scorable fundamental or attributed opinion.
stocktwits

+0.80 [social_text] “just burn it to 180” — The post asserts an explicit bullish price target for MRNA.
stocktwits

-0.70 [social_text] “$MRNA fk this” — The item is a strongly negative social expression directed at Moderna.
stocktwits

-0.40 [social_text] “Citi is still shorting and creating fear for their own selfish interest” — The attributed view that Citi's shorting is self-interested and fear-mongering is a negative opinion about the company's market environment.
stocktwits

-0.70 [social_text] “What a downgrade by Citi” — The post treats Citi's downgrade as a negative attributed analyst opinion.
stocktwits

-0.80 [social_text] “$MRNA rekt.” — The post expresses an extremely negative attributed opinion about Moderna.
stocktwits

+0.00 [social_text] “$MRNA buying up the dips…” — The item describes only MRNA's share-price behavior without a scorable fundamental or attributed opinion.
stocktwits

+0.60 [social_text] “3 idiots are bullish” — The author's attributed bullish view is a forward-looking opinion on MRNA.
stocktwits

+0.00 [social_text] “$MRNA showing great strength today as many of the biotechs tank.” — The item describes MRNA's relative price strength but provides no fundamental or attributed-opinion reason to score.
stocktwits

-0.70 [social_text] “f citi you guys suck just pure manipulation” — The post attributes a strongly negative manipulation thesis to Citi's view of Moderna.
stocktwits

+0.60 [social_text] “a stock that’s being accumulated for 10 weeks in a row and every dip gets bought” — The author describes a sustained accumulation pattern with repeated dip buying as a bullish signal.
stocktwits

+0.00 [social_text] “Expect a new high” — The item is a price prediction without a stated fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA 😊😊😊😊😊” — The item is only an untargeted bullish reaction with no company-specific fundamental or attributed-opinion proposition.
stocktwits

+0.70 [social_text] “9 long, zero short. Concentration in $PD and $MRNA by design — high-conviction over diversification.” — The author presents a high-conviction bullish thesis concentrated in Moderna.
stocktwits

+0.60 [social_text] “$MRNA Short sellers should rename themselves "short losers."” — The post is a bullish attributed opinion that short sellers are wrong about MRNA.
stocktwits

+0.80 [social_text] “October is where the move starts.” — The author presents a strongly bullish technical thesis for Regeneron.
stocktwits

+0.00 [social_text] “$MRNA 180 by Friday” — The item is a price target prediction, but it contains no stated fundamental reason or attributed opinion to score.
stocktwits

+0.60 [social_text] “things about to get wild lots and lots of shorts trapped here” — The post presents a bullish attributed thesis that many short positions will be trapped as MRNA moves above $200.
stocktwits

-0.60 [social_text] “Short sellers are total...” — The truncated social post expresses a strongly negative attributed opinion about short sellers.
stocktwits

-0.70 [news] “Citigroup just told investors to sell Moderna” — Citigroup's Sell rating is a strongly negative attributed analyst opinion.
Moderna Climbs 3% Despite Citigroup’s Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water

+0.00 [social_text] “$MRNA last one out, turn off the lights” — This is a price-blind observation of MRNA's investor attention without a stated fundamental reason or attributed opinion.
stocktwits

-0.60 [social_text] “the funding pull from the us government ain’t lol” — The post characterizes a U.S. government funding pullback as negative for Moderna.
stocktwits

-0.80 [social_text] “$C has warned that $MRNA can fall -60%” — The cited bearish thesis is a strong attributed negative opinion on Moderna's price.
stocktwits

+0.00 [social_text] “this loses that 49 percent” — The item reports MRNA's share-price decline without a stated fundamental reason.
stocktwits

-0.70 [social_text] “as if there’s not enough reason for this to tank” — The post expresses a strongly bearish opinion that further negative reasons for the stock are insufficient.
stocktwits

+0.00 [social_text] “$MRNA come on 190” — The item is only a price-level observation with no substantive MRNA fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “ur $MRNA poots way better now indra” — The item reports MRNA's share price improvement without stating a fundamental reason.
stocktwits

-0.80 [social_text] “$MRNA pure corruption.” — The post makes an explicit, strongly negative corruption allegation about Moderna.
stocktwits

+0.00 [social_text] “playing the swings daily for like $5” — The item describes MRNA's daily share-price movement without a scorable fundamental reason.
stocktwits

-0.70 [social_text] “EXIT LIQUIDITY phase” — The post asserts that Moderna is in an exit-liquidity phase, a strongly bearish attributed thesis.
stocktwits

+0.00 [social_text] “$MRNA come to 188 fast” — The item reports only a share-price observation without a scorable fundamental or attributed opinion.
stocktwits

-0.70 [social_text] “slipping back into the warm bath water of abysss” — The post expresses a strongly negative attributed view of Moderna's current situation.
stocktwits

-0.60 [social_text] “ohoh bad news” — The post expresses a strongly negative attributed opinion about Moderna.
stocktwits

-0.70 [social_text] “$MRNA 🗑️🗑️🗑️🗑️🗑️” — The repeated trash-can emojis express strongly negative social sentiment toward Moderna.
stocktwits

+0.00 [social_text] “Not loving the action today” — The item expresses a negative reaction to MRNA's reported price action but provides no fundamental reason to assign direction.
stocktwits

-0.70 [social_text] “$MRNA looks like one giant bull trap” — The post advances a bearish attributed thesis that MRNA is a bull trap.
stocktwits

-0.70 [social_text] “$MRNA party’s over sell off time” — The post expresses a strongly bearish attributed opinion that MRNA's rally has ended and a sell-off is underway.
stocktwits

-0.60 [news] “it could mean Moderna's upside is limited in the short-term” — The attributed bearish thesis limits Moderna's near-term upside.
After Moderna's 'Outsized Run,' It May Be Time For This Bearish Move

+0.00 [social_text] “$MRNA bore you out of your long bore you out of your short” — The item describes MRNA's price movement without a scorable fundamental reason.
stocktwits

+0.00 [social_text] “Lower highs?” — The item reports a technical price pattern without a scorable fundamental reason.
stocktwits

+0.00 [social_text] “seemed a little toppy” — The item describes MRNA's price behavior without a scorable fundamental or attributed opinion.
stocktwits

+0.60 [social_text] “the bears need a lesson” — The post is an explicitly bullish social opinion urging bears to reconsider their view of Moderna.
stocktwits

+0.00 [social_text] “who bought at 200 this Morning” — The post references MRNA's share price level but offers no fundamental or attributed directional opinion.
stocktwits

+0.60 [social_text] “back to our regularly scheduled bullish program” — The author characterizes Citi's prior shorting as timely and returns to a bullish program for MRNA.
stocktwits

+0.00 [social_text] “Interesting bounce at 1:44pm ET” — The item describes only a reported share-price move without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA send it” — The bare phrase is a generic social call to action that does not state a substantive company proposition.
stocktwits

-0.60 [social_text] “We would like to go upstairs.” — The quoted statement expresses a negative sentiment about the company's prospects.
stocktwits

+0.80 [social_text] “Please God $250” — The post expresses an explicit bullish price expectation for MRNA.
stocktwits

-0.70 [social_text] “they’ll drive the price down by at least 50% in a single day” — The attributed thesis describes a severe, rapid adverse price reaction to negative study or earnings results.
stocktwits

-0.80 [social_text] “Without a tyrannical government in the white house forcing you take this garbage- who’s gonna buy this crap?” — The attributed thesis claims government compulsion is the only reason demand exists, implying severe regulatory and political headwinds.
stocktwits

-0.60 [social_text] “Could you say the stock is overvalued?” — The author advances a bearish valuation thesis that MRNA's stock is overvalued.
stocktwits

+0.00 [social_text] “That just failed at a bad level. Seems we are pinned under.” — The item reports only a technical price failure without a stated fundamental reason.
stocktwits

+0.00 [social_text] “its up 2-3x in the last few months” — The reported share-price move is explicitly neutral under the price-blind rule.
stocktwits

-0.60 [social_text] “the company isnt profitable” — The author's stated view that the company lacks profitability is a negative fundamental proposition.
stocktwits

+0.40 [social_text] “the issue is the limbo it’s stuck In over the damn naked short selling.” — The author characterizes the naked shorting constraint as a limiting condition for MRNA.
stocktwits

+0.00 [social_text] “September's Leaders And Laggards $MRNA $FICO $INTC $DELL $META” — The item only identifies MRNA as a leader or laggard in a monthly performance list, which is a price observation and not a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “That was not an inspiring day.” — The item is a subjective observation about MRNA's day without a stated fundamental reason.
stocktwits

+0.00 [social_text] “$MRNA 160 during next few days” — The item is a price prediction without any stated fundamental or attributed-opinion reason.
stocktwits

+0.00 [social_text] “What a day.” — The item is a price-blind observation of MRNA's trading day without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “Big news from Citi already we have” — The item asserts a Citi development without stating a specific MRNA fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “Here comes the roosters.” — The item is a brief, non-substantive observation about MRNA that does not provide a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “Big news coming.” — The item promises unspecified future news without stating a directional fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “short is printing” — The observation describes short activity without a stated directional fundamental or attributed opinion about Moderna.
stocktwits

+0.00 [social_text] “Still sitting there on the trend line enjoying the view.” — The item describes MRNA's share-price behavior without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [news] “Moderna (MRNA) closed the most recent trading day at $188.94, moving 1.89% from the previous trading session.” — The item reports only a historical share-price move, which is explicitly neutral under the price-blind policy.
Moderna (MRNA) Stock Dips While Market Gains: Key Facts

+0.00 [social_text] “$IBRX $JNJ $MRK $MRNA $PFE” — The item lists MRNA alongside other companies without any company-specific proposition.
stocktwits

+0.00 [social_text] “$IBRX $PFE $MRNA $MRK $JNJ” — The item lists Moderna as one of several companies without providing any company-specific proposition.
stocktwits

+0.00 [social_text] “$IBRX $JNJ $MRNA $PFE” — The item lists multiple companies without providing any substantive proposition about Moderna.
stocktwits

+0.00 [social_text] “No worries .” — The item's only substantive proposition about Moderna is a neutral reassurance that carries no directional sentiment.
stocktwits

-0.70 [news] “a bearish Citi downgrade earlier this week” — Citi's bearish downgrade is a negative attributed analyst opinion.
Moderna Stock Is Trending: What's Going On?

+0.70 [social_text] “$MRNA is significantly undervalued.” — The author explicitly states a bullish valuation opinion on Moderna.
stocktwits

+0.80 [social_text] “this should be $30” — The post asserts a strongly bullish forward price target for Moderna.
stocktwits

+0.00 [social_text] “$MRNA $300” — The item reports only a share-price level without any substantive MRNA proposition.
stocktwits

-0.40 [social_text] “some guy from a hedge fund who doesn't know a shit about medicine took out his calculator and estimated that the price should be at 80” — The attributed valuation is presented as an incompetent and unreliable opinion.
stocktwits

+0.00 [social_text] “$MRNA $QQQ all the way to top 100” — The item reports MRNA's share-price movement without a scorable fundamental or attributed opinion.
stocktwits

+0.60 [social_text] “Let's see how the short sellers plunge into misery.” — The post expresses a strongly bullish attributed opinion that short sellers will suffer.
stocktwits

-0.50 [social_text] “hope isn't EBITDA” — The post warns that investor hope is not supported by MRNA's earnings measure.
stocktwits

+0.00 [social_text] “$MRNA September jobs report drops Friday 7:30 AM CT” — The item reports a macro employment event without stating a company-specific fundamental or attributed opinion.
stocktwits

+0.70 [social_text] “See you in $220+ tomorrow” — The post makes an explicitly bullish forward price prediction for Moderna.
stocktwits

+0.00 [social_text] “the real market start when CASH MARKET is open” — This is a neutral observation about when trading activity begins, not a substantive MRNA proposition.
stocktwits

+0.70 [social_text] “Roche/Genentech is validating the science.” — The attributed validation of the science is a positive forward opinion on the company's technology.
stocktwits

+0.00 [social_text] “the artificial price won’t survive the 100” — The item is a price-focused prediction without a stated fundamental reason for MRNA.
stocktwits

+0.70 [social_text] “See you at $200+” — The post expresses a bullish forward price opinion for Moderna.
stocktwits

+0.40 [social_text] “$MRNA people clearly don’t know what sell the news means.” — The post attributes a positive trading thesis to MRNA investors, though it is phrased as a criticism of their behavior.
stocktwits

+0.00 [social_text] “a ticker up 500% ytd” — The item reports MRNA's year-to-date price performance without a scorable fundamental or attributed opinion.
stocktwits

+0.60 [social_text] “Short DB's mostly sold and soon to go away: Susquehanna, Jane Street and Citadel cut their reported share holdings by 94%, 90% and 55%.” — The cited sharp reductions in short positions by major firms are attributed to a more favorable outlook for Moderna.
stocktwits

+0.00 [social_text] “Daily reminder for the shorts.” — The item is a generic reminder about short interest without stating a specific MRNA short thesis or directional opinion.
stocktwits

+0.00 [social_text] “this will touch 145 before close” — The item is a price prediction and therefore a neutral share-price observation.
stocktwits

+0.60 [social_text] “Citi did well on their call” — The attributed performance of Citi's call is a positive analyst opinion.
stocktwits

-0.60 [social_text] “Shorts gonna make bank on this one!” — The post expresses a bearish opinion that short positions will profit from MRNA's move.
stocktwits

+0.60 [social_text] “$MRNA JUNK” — The item is a strongly bullish social opinion about Moderna.
stocktwits

+0.00 [social_text] “$MRNA Bounced off of $192.90 two or three times.” — The item describes Moderna's share-price behavior without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “Someone just purchased 3000 contracts on $205 calls today’s expiary at $0.15” — The reported options purchase is a price-blind trading observation without a stated fundamental reason.
stocktwits

+0.40 [social_text] “$MRNA weak” — The attributed social opinion characterizes MRNA as weak, a moderately bullish sentiment.
stocktwits

+0.00 [social_text] “If she manages to break $196 may go $200+ quickly” — The item is a conditional price prediction and contains no scorable fundamental or attributed opinion about Moderna.
stocktwits

+0.00 [social_text] “this spikes to $200+” — The item only reports a potential share-price move without a substantive MRNA fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “Next 5 minutes defines the day?” — The item is a price-focused question about MRNA with no stated fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “Moderna is gaining after Nasdaq announced it will replace Warner Bros. Discovery in the Nasdaq-100 on October 9.” — The item reports Moderna's share-price reaction to an index membership change, which is a neutral company observation.
stocktwits

-0.40 [social_text] “feel free to try your luck and short this today” — The attributed short thesis treats today's move as a favorable opportunity to short MRNA.
stocktwits

+0.00 [social_text] “$MRNA $500” — The item reports only a share-price level without any company-specific fundamental or attributed opinion.
stocktwits

-0.60 [social_text] “$MRNA pump and dump in first 30 minutes.” — The post alleges a coordinated pump-and-dump manipulation of MRNA shares.
stocktwits

+0.00 [social_text] “Moderna (MRNA) up 0.5% after being named to replace Warner Bros. Discovery (WBD) in” — The item reports Moderna's share-price movement without stating a substantive company-specific reason.
stocktwits

+0.00 [social_text] “$MRNA looks like big profit taking today.” — The item describes a price-driven profit-taking move without a scorable fundamental reason.
stocktwits

+0.60 [social_text] “Selling about to be cranked up to 11 Won’t maintain” — The author argues that heavy selling is temporary and that the stock will not sustain its decline.
stocktwits

+0.00 [social_text] “$160S?” — The item is a price-level question about MRNA without a stated fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA $5 dump from pm highs” — The item reports only a share-price move without a scorable fundamental reason.
stocktwits

-0.60 [social_text] “$MRNA jobs won’t save you bulls” — The item explicitly rejects a bullish thesis that jobs will benefit MRNA.
stocktwits

+0.70 [social_text] “I will take $220” — The author's stated willingness to buy at $220 is a bullish forward opinion.
stocktwits

+0.60 [social_text] “My $MRNA and $CRWD shorts are toasted I guess” — The author's attributed view is that the short position on Moderna is likely to perform well.
stocktwits

+0.00 [social_text] “if only they would let me buy with new funds” — The user's inability to purchase shares is a reported transaction observation, not a scorable MRNA fundamental or attributed opinion.
stocktwits

+0.60 [social_text] “real investors are going to make bank on your short term backs.” — The author characterizes the setup as a favorable short-term trading opportunity.
stocktwits

+0.70 [social_text] “$MRNA beautifull and strong!” — The post expresses a strongly positive attributed opinion about Moderna.
stocktwits

+0.00 [social_text] “$MRNA green” — The item reports only a share-price observation without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “to tha moon” — The post is a generic bullish price observation with no company-specific fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA just reversed hard” — The item reports only a price reversal without a stated fundamental reason.
stocktwits

+0.00 [social_text] “what a reversal” — The item describes MRNA's price action without stating a fundamental reason or attributed opinion.
stocktwits

+0.00 [social_text] “turning green today” — The item reports only a potential intraday price move, which is neutral under the price-blind policy.
stocktwits

+0.00 [social_text] “$MRNA send it $200+ on shorts” — The post is a speculative, humorous claim about a potential price move rather than a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “red to green about to come in” — The item reports only a color-coded share-price move without a scorable fundamental or attributed opinion.
stocktwits

-0.70 [social_text] “one of the market's most hated stocks” — The post characterizes MRNA as widely disliked by investors.
stocktwits

+0.00 [social_text] “Those are now up over 100%” — The item reports only MRNA's share-price movement, which is explicitly neutral.
stocktwits

-0.70 [social_text] “$TSLA no longer a growth stock, even stationary storage is losing sales and that was tsla last growth product” — The attributed thesis that Tesla is no longer a growth stock and that its last growth product is losing sales is strongly negative.
stocktwits

+0.00 [social_text] “seems to be holding support zone” — The support-zone observation is a technical price observation and carries no directional sentiment.
stocktwits

+0.60 [social_text] “$MRNA pigs get slaughtered.” — The idiom implies a strongly bullish view that MRNA is undervalued and due for a rebound.
stocktwits

+0.00 [social_text] “$MRNA you must be MEGA to buy this” — The post is a target-specific observation about investor attention that carries no directional fundamental or attributed opinion.
stocktwits

+0.60 [social_text] “that good news” — The user characterizes the company's news as good, expressing bullish sentiment.
stocktwits

+0.00 [social_text] “$MRNA going down” — The item reports only MRNA's share-price movement, which is explicitly price-blind and directionally neutral.
stocktwits

-0.80 [social_text] “only the beginning of capitulation. It has a long way down to go” — The post expresses a strongly bearish attributed opinion that further downside remains.
stocktwits

+0.00 [social_text] “ok grabbed small $190 calls for end of day looking for $190+ spike or even $200 potential if it breaks $195” — The item is a price-based trading speculation about MRNA without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA so we have a realt life Nostradamus here!” — The item is a bare, non-substantive remark about MRNA that does not present a scorable company proposition.
stocktwits

-0.60 [social_text] “the campers are here because of the future” — The post mocks MRNA's investor base and its forward-looking outlook.
stocktwits

+0.60 [social_text] “Possibility still of a one trillion dollar market cap” — The attributed possibility of a trillion-dollar market cap is a moderately bullish forward opinion.
stocktwits

+0.60 [social_text] “Sellas MC will surpass $MRNA post GPS Regal Pivotal Registrational phase 3 study Curative results.” — The post asserts a favorable regulatory outcome for SLS relative to MRNA's curative results.
stocktwits

+0.00 [social_text] “$IBRX $MRNA $SLS $GRAL $IOVA next week eyes on” — The post lists MRNA among several names being watched, but offers no directional judgment about MRNA itself.
stocktwits

+0.00 [social_text] “why your price so low” — The post is a price-blind observation of MRNA's share price without a scorable fundamental reason.
stocktwits

+0.00 [social_text] “$MRNA getting ready to go under 187 again” — The item reports a prospective share-price level without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA taking profit here 190 from the 185 buy call” — Taking profit is a neutral observation of a trade execution and does not constitute a scorable fundamental or attributed opinion about Moderna.
stocktwits

+0.00 [social_text] “Back to regular pricing.” — The item reports a price normalization without stating a substantive MRNA fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “Can be big if this breaks $195 today volume on day still 5.5M” — The item is a price-blind technical observation about MRNA's share price and volume.
stocktwits

+0.80 [social_text] “$MRNA free money as always with this!” — The user's exclamation is an explicitly bullish attributed investment opinion.
stocktwits

+0.60 [social_text] “$195 lotto calls around $0.10 cents” — The post expresses a bullish option thesis on MRNA by describing a speculative call-purchase strategy.
stocktwits

+0.00 [social_text] “liberals pile into $MRNA” — The item reports a social-media observation of MRNA investor attention without a substantive company proposition.
stocktwits

+0.00 [social_text] “Moderna MC is now over $75 Billion post phase 3 results.” — The market-cap observation is a neutral company fact and does not establish a directional fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$ABBV $MRNA $SLS $XBI “Imminent” is a relative term. 😂 Happy Friday yall!” — The item is a generic, non-directional Friday remark that does not advance a substantive proposition about Moderna.
stocktwits

-0.70 [social_text] “an analyst came out with a $80 PT and sell down rating.” — The attributed analyst thesis combines a lower price target with a downgrade, a strongly negative forward opinion.
stocktwits

+0.00 [social_text] “$MRNA broke vwap” — Breaking VWAP is a reported technical price observation with no stated fundamental direction.
stocktwits

+0.80 [social_text] “Gps will Generate Peak Revenue north of $10B just for AML Remission Maintenance.” — The item forecasts very large peak revenue from the GPs program for AML remission maintenance.
stocktwits

+0.40 [social_text] “Watching for a SELL off into close to end the week” — The author expects a short-term sell-off, which is a bullish attributed trading expectation for MRNA.
stocktwits

+0.00 [social_text] “change of plan for $MRNA , it already has 3 touches & bounce of vwap, now fourth one underway, we will short it if loses VWAP not bounce to 191 ish” — The item describes a technical trading plan and a conditional short thesis, but provides no fundamental or attributed opinion about Moderna itself.
stocktwits

+0.00 [social_text] “cant wait for this to hit $170S to $150S next week” — The item is a price target expectation, which is a neutral reported price observation.
stocktwits

-0.60 [social_text] “watching $MRNA 191 zone for a potential short” — The attributed trading thesis identifies a specific price zone as a potential short opportunity.
stocktwits

+0.40 [social_text] “The co-founder and chairman Noubar Afeyan has a lot of experience with acquisitions of companies that he's helped build.” — The attributed experience supports a moderately positive view of Moderna's acquisition capability under its leadership.
stocktwits

-0.60 [social_text] “would have expected to be up 2-4 after 100 announcement. Did not meet the acid test.” — The author expected a positive reaction to the announcement and concludes the result was disappointing.
stocktwits

+0.00 [social_text] “more drop ahead” — The item reports only a further share-price decline without a stated fundamental reason.
stocktwits

+0.00 [social_text] “October 24th place your bets .” — The item is a generic trading prompt without a substantive proposition about Moderna.
stocktwits

+0.40 [news] “Moderna (NasdaqGS:MRNA) appointed Juan Andres as its first Chief Operating Officer as it reshapes its leadership structure.” — Creating a dedicated COO role and appointing experienced leadership to scale manufacturing is a positive operational development.
Why Is Moderna (MRNA) Bringing Back A Manufacturing Leader As First COO?

+0.00 [social_text] “hope isn't EBITDA” — The item is a neutral reminder about the difference between hope and earnings, without a specific MRNA proposition.
stocktwits

+0.00 [social_text] “$MRNA $RIVN $SG not too shabby for these picks.” — The post is a neutral observation about the author's portfolio performance rather than a scorable company proposition.
stocktwits

+0.00 [social_text] “$MRNA 210 call 11/06.” — The item is a neutral observation of an upcoming MRNA earnings call with no substantive directional proposition.
stocktwits

+0.00 [social_text] “Stay quiet & keep getting exposed for the grifters you are.” — The item is a generic social call to silence that does not state a substantive proposition about Moderna.
stocktwits

+0.00 [social_text] “Everyone with eyes & a brain sees you've been obsolete for years.” — The item is a substantive but directionless social observation about Moderna's standing.
stocktwits

-0.80 [social_text] “Israel covered up hundreds of COVID vaccine deaths” — The item makes a serious, strongly negative allegation about vaccine deaths and concealment.
stocktwits

+0.00 [social_text] “Can’t wait for Monday!” — The post expresses anticipation but states no substantive fundamental or attributed opinion about Moderna.
stocktwits

+0.00 [social_text] “$MRNA 180C 280% $990 gains” — The item reports MRNA's share price movement without a scorable fundamental reason.
stocktwits

+0.00 [social_text] “$MRNA 180C 420% $1400 gains” — The item reports only MRNA's share-price movement, which is explicitly neutral.
stocktwits

+0.00 [social_text] “$MRNA 200P 180%” — The item reports only a historical share-price move for Moderna, which is neutral under the price-blind policy.
stocktwits

+0.00 [social_text] “It closed Tuesday at 203.46, back above the trigger, which stings.” — The item describes MRNA's price movement and a trader's reaction without a scorable fundamental or attributed opinion.
stocktwits

+0.60 [social_text] “$MRNA $MRNX $NTRA buy the pullbacks.” — The author explicitly recommends buying MRNA on pullbacks, expressing a bullish attributed opinion.
stocktwits

+0.00 [social_text] “Been defending 10ma 3 days in a row. Would like to see turn around here to reattack the highs” — The item describes only technical price behavior without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “let open a little something here tomorrow just incase.” — The item is a speculative comment about MRNA's share price movement without a stated fundamental reason.
stocktwits

+0.00 [social_text] “Balls Deep?” — The headline is a price-related observation without a stated fundamental reason.
stocktwits

+0.00 [social_text] “pandemic fears from Russia” — The item offers only speculative pandemic-related market sentiment without a stated fundamental reason for MRNA.
stocktwits

+0.00 [social_text] “$MRNA $500” — The item reports only a share-price level without any company-specific fundamental or attributed opinion.
stocktwits

+0.70 [social_text] “Moderna is flashing a powerful Elliott Wave bullish signal, with momentum building in Wave III.” — The item presents a bullish technical analysis thesis about Moderna's price pattern and momentum.
stocktwits

+0.00 [social_text] “$MRNA was terrible stock and everyone hated it, now it gained 5x in few months” — The item's historical comparison of Moderna's performance is a neutral observation and does not constitute a current directional proposition.
stocktwits

+0.00 [social_text] “Top Day2 Morning Short & Mid Day 5/12 Curl Long Setup” — The item describes a repeatable trading pattern without stating a company-specific fundamental or attributed opinion.
stocktwits

+0.80 [social_text] “go up 150-200%” — The item asserts a very large bullish price move for MRNA.
stocktwits

+0.00 [social_text] “Weak again watching for $180 test lower” — The item reports only MRNA's share-price behavior without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA is cliff hanging and looking a little weak today.” — The item describes MRNA's reported intraday price behavior without a scorable fundamental reason.
stocktwits

+0.60 [social_text] “I am bullish long term” — The user expresses a positive long-term opinion about Moderna.
stocktwits

+0.00 [social_text] “$RXRX LFG! $SPY $MRNA” — The post is a generic bullish reaction to another company and only mentions MRNA as an incidental tag.
stocktwits

+0.00 [social_text] “$220 C on watch end of week” — The item is a price-target observation but contains no substantive fundamental or attributed directional opinion about Moderna.
stocktwits

+0.00 [social_text] “The recent run up was simply phenomenal.” — The item describes only MRNA's recent share-price movement, which is explicitly price-blind.
stocktwits

-0.70 [social_text] “$MRNA bears suck at this so bad.” — The post expresses a strongly negative attributed opinion about Moderna's investment case.
stocktwits

+0.00 [social_text] “Will try and enter on a broader market dip.” — The post describes a general market entry plan rather than a substantive proposition about Moderna.
stocktwits

+0.00 [social_text] “Held 10ma 3 days in a row last week. Now breaking above.” — The item describes a technical price pattern without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA Dolly Parton Money” — The post is a bare mention of MRNA without a substantive company proposition.
stocktwits

-0.80 [social_text] “The scam is still scamming” — The post expresses a strongly negative attributed opinion about Moderna.
stocktwits

+0.00 [social_text] “$MRNA volatility is slowing.” — Slowing volatility is a price-market observation and therefore neutral.
stocktwits

+0.00 [social_text] “did short $pcvx when cubie said it aint gonna pull $MRNA $KOD ?” — The item is only about short interest in a different company (PCVX) and does not present a substantive proposition about Moderna.
stocktwits

+0.00 [social_text] “$MRNA $230” — The item reports only a share price level without any substantive company proposition.
stocktwits

+0.00 [social_text] “what happens when the forced buying ends Friday” — The item describes a potential price move without stating a company-specific fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA citi.” — The item is a bare mention of Citi with no stated opinion or fundamental proposition about Moderna.
stocktwits

+0.60 [social_text] “$MRNA 250 soon then 300” — The post forecasts two rising price targets for MRNA.
stocktwits

-0.60 [social_text] “$MRNA bears are still in disbelief” — The post attributes a negative disbelief sentiment to bears about MRNA.
stocktwits

+0.00 [social_text] “more.than couple days😅” — The post is a bare, non-substantive remark about MRNA that does not present a scorable company proposition.
stocktwits

+0.00 [social_text] “citi asks to sell and the price goes up” — The item presents a bearish analyst opinion alongside a price move, but the move itself is not scorable.
stocktwits

-0.70 [social_text] “I’m done losing money on this one” — The author expresses a strongly negative personal sentiment about the investment.
stocktwits

+0.60 [social_text] “the secondary asset Prior Phase 2B results ... better than Magrolimab in the Same AML-MR setting” — The author's comparison suggests the secondary asset shows stronger Phase 2B results than a relevant competitor.
stocktwits

+0.70 [social_text] “$210 inbound this week” — The post presents an explicit bullish price-target opinion for Moderna.
stocktwits

+0.60 [social_text] “this seems like logical play here & acting well” — The user's favorable assessment of the investment play is a positive attributed opinion.
stocktwits

+0.00 [social_text] “it is going to be another DJT” — The item is a price-blind comparison to another stock and contains no MRNA-specific fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA must be mega buying this trumpet” — The item is a price-blind observation of investor attention without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA timberrrrr.....” — The item is only a bare price-related exclamation with no substantive MRNA proposition.
stocktwits

+0.00 [social_text] “$MRNA i literally missed this one” — The post expresses a personal trading miss but contains no substantive company proposition.
stocktwits

+0.00 [social_text] “glad I bought a few more this morning” — The item is a price-blind observation of the user's share purchase, not a scorable MRNA fundamental or attributed opinion.
stocktwits

+0.60 [social_text] “$MRNA 220 would be great” — The user expresses a favorable forward price target for Moderna.
stocktwits

-0.70 [social_text] “Covid cases double in a month and hospital admissions rise five-fold” — Rapid doubling of cases and a five-fold rise in hospitalizations indicate severe and accelerating public-health pressure.
stocktwits

+0.00 [social_text] “i am just out $205, i bought it onlt 500 share at $196” — The item reports only MRNA's share-price movement, which is explicitly neutral.
stocktwits

-0.60 [social_text] “Retail needs to capitulate.” — The attributed thesis expects further retail capitulation before a broader rally.
stocktwits

+0.00 [social_text] “about to dump under 200 in minutes” — The item is a price prediction and contains no scorable fundamental or attributed opinion about Moderna.
stocktwits

+0.70 [social_text] “$MRNA buy $NVAX the next 10x” — The post is an attributed bullish investment thesis on Moderna's future performance.
stocktwits

+0.00 [social_text] “ha back down soon” — The item is a bare prediction of a share-price move with no stated fundamental reason.
stocktwits

+0.00 [social_text] “there is your 12 month high bulls” — The item reports MRNA's share-price milestone without a scorable fundamental or attributed opinion.
stocktwits

+0.60 [social_text] “marketcap was 11 billion end of last year now its 81 billion” — The stated increase in Moderna's market capitalization is a positive company observation.
stocktwits

+0.00 [social_text] “$MRNA 350$ gap up” — The item reports only MRNA's share-price movement, which is explicitly neutral.
stocktwits

+0.00 [social_text] “$NVAX woah $MRNA” — The post mentions Moderna only as a name-drop without a substantive company proposition.
stocktwits

-0.70 [social_text] “This overvalued cash burning ticker need cool of.” — The attributed thesis characterizes Moderna as overvalued and burning cash, a negative fundamental assessment.
stocktwits

+0.00 [social_text] “I need as many people as possible to believe this” — The post expresses a desire for belief but provides no substantive MRNA proposition.
stocktwits

+0.00 [social_text] “when its included in the Nasdaq” — Nasdaq inclusion is a neutral index-membership observation with no stated fundamental impact.
stocktwits

+0.00 [social_text] “$MRNA squeeze this 💣💣📈” — The item reports a price squeeze without stating a scorable fundamental reason.
stocktwits

+0.00 [social_text] “$MRNA are you guys looking at SGIOY too???” — The post asks about another company and does not present a substantive proposition about Moderna.
stocktwits

+0.00 [social_text] “ignore that voice in the back or your head that is saying to sell” — The item is a neutral observation about an internal selling impulse rather than a scorable MRNA fundamental or attributed opinion.
stocktwits

+0.70 [social_text] “IST MEIN TOP PIG FÜR DIE NÄCHSTEN JAHRE.” — The user's statement is a strongly positive attributed investment thesis about Moderna.
stocktwits

+0.00 [social_text] “$MRNA not giving anything back… that’s strength” — The item is a price-blind observation of MRNA's share movement without a scorable fundamental reason.
stocktwits

-0.40 [social_text] “$NVAX is superior to $MRNA in everything.” — The attributed comparison asserts that Moderna is inferior across all dimensions.
stocktwits

+0.00 [social_text] “$MRNA big flush in 5 minutes” — The item describes only a short-term share-price move without a stated fundamental reason.
stocktwits

+0.00 [social_text] “$MRNA would love some of that love!” — The post expresses a neutral observation about investor attention rather than a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “⬇️ $SPY ” — The item reports only a price movement, which is explicitly neutral under the price-blind policy.
stocktwits

+0.40 [social_text] “how $MRNA, $NVAX and $AIRDF are expanding access through new therapies, global commercialization and virtual care” — The item presents Moderna's therapy expansion and commercialization as a positive access proposition.
stocktwits

+0.00 [social_text] “$MRNA $230” — The item reports only a share price level without any substantive MRNA proposition.
stocktwits

+0.00 [social_text] “$NVAX long over due for a major squeeze $MRNA” — The item is a comparative investment observation about Moderna rather than a scorable fundamental or attributed opinion about Moderna.
stocktwits

+0.00 [social_text] “keep switching sides” — The post's only company-specific proposition is a neutral observation about MRNA's share-price behavior.
stocktwits

+0.00 [social_text] “$MRNA has been treating me good this yr.” — The item reports only MRNA's historical share performance, which is a price-blind observation.
stocktwits

+0.00 [social_text] “$MRNA had 200 res then broke to 205.77” — The item reports only MRNA's price action without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “Mostly $SPCX $MRNA carried the markets today.” — The item reports MRNA's market performance without a stated fundamental reason.
stocktwits

+0.00 [social_text] “$MRNA closed up 7% at 203.21” — The item reports MRNA's price movement without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA 215C above 211” — The item reports only a price level above a threshold, which is a neutral observation under the price-blind rule.
stocktwits

+0.00 [social_text] “$JNJ $MRNA $DJI $BTC.X $SPY” — The item lists MRNA alongside other assets without a substantive company proposition.
stocktwits

+0.00 [social_text] “3/19 2027 calls up about 3000%” — The reported option price move is a market observation and carries no directional sentiment under the price-blind rule.
stocktwits

+0.00 [social_text] “Share Price: $203.21” — The reported share price is a neutral observation and does not constitute directional sentiment.
stocktwits

+0.00 [social_text] “Sandisk $SNDK is the best-performing S&P 500 stock this year just like it was in 2025.” — The item reports Sandisk's share performance, which is a price observation and therefore neutral.
stocktwits

+0.00 [social_text] “SELL/TAKE PROFIT ON 10% of net long position.” — The item is a neutral trading-management instruction rather than a substantive MRNA fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$SPCX 175C above 171.08, $MRNA 215C above 211, $TSLA 382.50C above 380 and $TER 440P below 444.53 make up the team's Tuesday Trade Plan.” — The item presents MRNA's level as a neutral observation within a multi-stock trading plan.
stocktwits

-0.80 [social_text] “180 before you can say overvalued” — The attributed opinion asserts that MRNA is substantially overvalued.
stocktwits

-0.40 [social_text] “Trims at 4.40 (70%+). Stops BE+ lehgooooo” — The user's aggressive trimming and stop adjustment indicate a negative trading conviction in MRNA.
stocktwits

+0.00 [social_text] “Trading $MRNA Daily & Weekly Chart Breakout Long Winner Setup” — The item describes a technical chart pattern without a stated fundamental or attributed opinion about Moderna.
stocktwits

-0.60 [social_text] “Can’t trade at 32x earnings forever” — The attributed thesis is that MRNA's valuation is unsustainably high.
stocktwits

+0.60 [social_text] “still on track” — The social post asserts that MRNA remains on track, a moderately positive forward-looking company observation.
stocktwits

+0.00 [news] “there was a "low" risk of a plague epidemic” — The WHO's low-risk assessment is a neutral company-irrelevant observation about plague risk.
Novavax, Moderna stocks fall after WHO calls plague risk 'low'

-0.60 [social_text] “the stock is worth 80-100” — The author's stated valuation range implies MRNA is materially overvalued at the current price.
stocktwits

-0.70 [social_text] “No new pipeline” — The absence of new pipeline developments is a negative proposition about MRNA's development progress.
stocktwits

-0.70 [social_text] “VIALE-C - C Trial Failure” — The trial failure of the VIALE-C trial is a negative clinical outcome for MRNA's venetoclax program.
stocktwits

+0.00 [social_text] “$FIL.X = $MRNA” — The comparison is not supported by any substantive proposition about Moderna.
stocktwits

+0.80 [social_text] “SLS is the Investment opportunity of a lifetime.” — The author presents an explicitly bullish investment thesis for SLS.
stocktwits

+0.60 [news] “The pipeline promise is real” — The source affirms Moderna's pipeline as a credible positive proposition.
Moderna Is Up 545% in 2026: Take Profits Now, or Keep Buying?

+0.80 [social_text] “I see 80$ after ESMO Congress full results.” — The user's stated post-congress price target is a strongly bullish attributed forward opinion.
stocktwits

+0.90 [social_text] “SLS Phase 3 Patients Living 3x 4x longer than on SOC/BAT” — The Phase 3 patient outcomes are presented as substantially better than standard-of-care and prior treatments.
stocktwits

-0.80 [social_text] “Wildly overvalued” — The attributed thesis is that Moderna's valuation is excessively high.
stocktwits

+0.60 [news] “Moderna (MRNA) appointed former executive Juan Andres as its new Chief Operating Officer in a newly created role” — The new COO appointment adds operational leadership and information value to Moderna.
Moderna (MRNA) Could Be 57% Above Fair Value On New COO Appointment

+0.40 [social_text] “Tempus expands collaboration with $MRNA Moderna and $MRK Merck on cancer therapy” — Expanding the collaboration is a positive development for Moderna's therapeutic partnership.
stocktwits

-0.80 [social_text] “but the Survival is Not Durable” — The attributed trial conclusion states that survival durability is not achieved.
stocktwits

+0.60 [social_text] “Updated RSV/flu combo vaccine data and ongoing respiratory season sales trends are back in focus.” — Updated vaccine data and ongoing respiratory sales trends are positive company fundamentals.
stocktwits

+0.70 [social_text] “when sales are rocking again then 500” — The post expresses a strongly bullish attributed opinion that MRNA sales will recover and expand substantially.
stocktwits

-0.70 [social_text] “Morgan Stanley and Citibank sub $100 PTs” — Two major banks' sub-$100 price targets constitute a strongly negative attributed analyst opinion.
stocktwits

+0.00 [social_text] “$MRNA Moderna Stock Price Prediction 2026, 2030, 2040” — The item is only a title about Moderna's future stock price; it provides no substantive fundamental or attributed opinion to score.
stocktwits

-0.40 [social_text] “pushed through resistsnce there some fight left but still think its comes down.” — The post describes a failed resistance test and expected further weakness in MRNA's price action.
stocktwits

+0.00 [social_text] “$MRNA mooning” — The item reports only a share-price move without a scorable fundamental or attributed opinion.
stocktwits

+0.70 [social_text] “Mrna is going hit ath imo” — The user's prediction that Moderna will hit an all-time high is a bullish attributed opinion.
stocktwits

+0.00 [social_text] “$250 is almost here” — The item is a price-level observation with no stated fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “see you back at 193.60 EOD” — The item is a price-blind prediction of MRNA's closing share price, which is a neutral observation.
stocktwits

+0.00 [social_text] “$CAPR starting to get some momentum” — The item reports only a price-momentum observation for Capricor, which is not a scorable MRNA proposition.
stocktwits

+0.60 [social_text] “Expect $205” — The user's attributed expectation of a $205 price target is a positive forward opinion.
stocktwits

+0.00 [social_text] “$MRNA is flying” — The item reports only MRNA's share-price movement, which is explicitly price-blind and carries no fundamental direction.
stocktwits

+0.00 [social_text] “$MRNA Show us 205!” — The post is a price target that does not state a fundamental reason for MRNA's performance.
stocktwits

+0.00 [social_text] “tomorrow new higher high” — The item reports a price high without stating any underlying fundamental reason.
stocktwits

+0.00 [news] “Moderna, Eli Lilly Lead Healthcare Stocks Higher on a Down Day for Markets” — The item reports Moderna's share-price performance without a company-specific fundamental or attributed opinion.
Moderna, Eli Lilly Lead Healthcare Stocks Higher on a Down Day for Markets

+0.70 [social_text] “I will see you at $250 soon” — The author's bullish forecast is an attributed forward opinion on MRNA's price.
stocktwits

+0.40 [news] “maintains Moderna (NASDAQ:MRNA) with a Equal-Weight and raises the price target from $89 to $95.” — Morgan Stanley's maintained Equal-Weight rating and higher price target constitute a moderately positive attributed analyst opinion.
Morgan Stanley Maintains Equal-Weight on Moderna, Raises Price Target to $95

+0.00 [social_text] “$MRNA head and shoulders?” — The item is a price-blind technical-pattern question that does not state a fundamental reason or attributed opinion.
stocktwits

+0.00 [social_text] “Share Price: $196.46” — The reported share price is a neutral observation and does not constitute directional sentiment.
stocktwits

+0.70 [social_text] “$MRNA 304.80+ someday” — The post expresses a bullish forward price opinion for Moderna.
stocktwits

+0.00 [social_text] “$204.38” — The item reports a specific share price without any stated fundamental reason or attributed opinion.
stocktwits

+0.00 [social_text] “why did this POS go up today while other bios ended down for the day” — The item is a price-blind observation of MRNA's relative daily move without a scorable fundamental reason.
stocktwits

+0.00 [social_text] “head and shoulders??” — The item presents a technical pattern observation without a stated directional conclusion.
stocktwits

+0.00 [social_text] “$MRNA $170?” — The item is only a speculative price question with no stated fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “Momentum names are CRASHING TODAY” — The item reports a broad price move without a specific fundamental reason for Moderna.
stocktwits

+0.70 [social_text] “let's break 200 and let's start our beautiful journey into la la land $500++” — The post expresses a strongly bullish attributed opinion that MRNA will break $200 and reach $500.
stocktwits

+0.00 [social_text] “if the gap is filled at 200, it will squeeze to 210 again” — The item is a price-level technical observation with no stated fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA didn’t even touched 200” — The item reports only a share-price observation without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA reverse” — The item reports only a share-price reversal without a stated fundamental reason.
stocktwits

+0.00 [social_text] “$MRNA could end 10% down for the day at this rate.” — The item reports only a potential intraday share-price move, which is explicitly neutral under the price-blind policy.
stocktwits

+0.00 [social_text] “$MRNA 220” — The item reports only MRNA's share price without any fundamental or attributed-opinion proposition.
stocktwits

+0.70 [social_text] “another $80 PT this morning from Evercore ISI” — Evercore ISI's bullish price target is a positive attributed analyst opinion.
stocktwits

+0.00 [social_text] “$MRNA on the sidelines until 3:59” — The item reports MRNA's share-price position without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA doing great considering market today” — The item is a price-blind observation of MRNA's performance relative to the market, which carries no directional sentiment.
stocktwits

+0.00 [social_text] “$QQQ going for fresh lows, lot of unwinds today.” — The item describes a broad market unwind and does not state a company-specific fundamental or attributed opinion about Moderna.
stocktwits

+0.00 [social_text] “the entire market is red” — The item reports a broad market move without a substantive proposition about Moderna.
stocktwits

+0.00 [social_text] “$MRNA heading to 200.” — The item is only a price prediction and contains no scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “wonderful short down to the Multiday VWAP for a cover and scalp long” — The item describes MRNA's share-price movement without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “Back above 200.” — The item reports a share-price level without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$HOOD - Puts are paying below $112.57. Now targeting $109.53” — The item's substantive sentiment is about Hood, not Moderna.
stocktwits

+0.00 [news] “Moderna, Inc. (Nasdaq: MRNA) will become a component of the Nasdaq-100 Index® (NDX®) replacing Warner Bros. Discovery, Inc. (Nasdaq: WBD)” — Moderna's addition to the Nasdaq-100 is a neutral index membership change.
Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026

+0.00 [social_text] “MRNA Lands A Nasdaq-100 Spot” — Nasdaq-100 membership is a neutral index-change observation with no stated fundamental direction for Moderna.
stocktwits

+0.00 [social_text] “Moderna, Inc. (Nasdaq: MRNA) will become a component of the Nasdaq-100 Index®” — Moderna's addition to the Nasdaq-100 is a neutral index membership observation.
stocktwits

+0.00 [social_text] “Moderna, Inc. (Nasdaq: MRNA) will become a component of the Nasdaq-100 Index (NDX) replacing Warner Bros. Discovery, Inc. (Nasdaq: WBD)” — Moderna's Nasdaq-100 inclusion is a neutral index membership change with no stated fundamental direction.
stocktwits

+0.00 [social_text] “Index reshuffle alert: $MRNA is set to join the Nasdaq-100” — Nasdaq-100 membership is a neutral index-change observation with no stated fundamental direction.
stocktwits

+0.00 [news] “Moderna will replace Warner Bros. Discovery in the Nasdaq-100 before markets open on Oct.9.” — Moderna's Nasdaq-100 inclusion is a neutral index membership change.
SLS, IBRX Stocks Climb Overnight: Retail Eyes Moderna’s Rally As MRNA Lands A Nasdaq-100 Spot

+0.00 [social_text] “added to Nasdaq 100” — The question is a neutral observation about Nasdaq 100 membership without a stated company-specific outcome.
stocktwits

+0.00 [social_text] “MY #1 YOLO STOCK?” — The post is a promotional call to join a trading community rather than a substantive proposition about Moderna.
stocktwits

+0.00 [social_text] “Moderna will be included into the NASDAQ 100 on October 9. It will be replacing Warner Brothers.” — Moderna's upcoming NASDAQ 100 inclusion is a neutral index membership change.
stocktwits

+0.00 [news] “Moderna is joining the Nasdaq-100.” — Moderna's Nasdaq-100 inclusion is a neutral index membership observation.
Wall Street Breakfast Podcast: No Sprint For Nike Yet

+0.00 [social_text] “Moderna will replace Warner Bros. Discovery in the index Oct 9” — Moderna's future Nasdaq-100 membership is a neutral company observation.
stocktwits

+0.00 [social_text] “Moderna joins the Nasdaq-100 before the open on Oct 9” — Nasdaq-100 inclusion is a neutral index-membership observation with no stated fundamental direction.
stocktwits

+0.00 [social_text] “$MRNA joining spy ?” — The post is a speculative question about possible S&P 500 membership and contains no substantive sentiment about Moderna.
stocktwits

+0.00 [social_text] “$MRNA cup and handle forming?” — The item is a price-blind technical-pattern question that does not establish a substantive directional opinion.
stocktwits

+0.00 [social_text] “$MRNA 25k followers on a guy who can trade the moving average line” — The item is a neutral observation about social attention to MRNA without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “the big boys are bringing the stock down because they have to buy 15 to 20,000,000 shares between today and October 9 when it lists on the NASDAQ 100” — The anticipated NASDAQ 100 listing and associated share purchases are a neutral company observation.
stocktwits

+0.00 [social_text] “$MRNA to join NASDAQ 100, replacing Warner Bros” — NASDAQ-100 membership is a neutral index composition observation with no stated fundamental impact.
stocktwits

+0.00 [social_text] “Moderna will replace Warner Bros. Discovery in the Nasdaq-100 before markets open on Oct.9.” — Moderna's upcoming Nasdaq-100 replacement is a neutral index membership observation.
stocktwits

+0.00 [social_text] “$MRNA guys what do you think of $HOUR stock???” — The post is a social question about Hour Health, not a substantive proposition about Moderna.
stocktwits

+0.00 [social_text] “Moderna to replace Warner Bros Discovery on Nasdaq 100” — Moderna's replacement on the Nasdaq 100 is a neutral index membership change.
stocktwits

+0.70 [social_text] “This tech can help in responding and protecting people quickly.” — The attributed view characterizes MRNA's technology as effective for rapid disease response and protection.
stocktwits

+0.00 [social_text] “Its being included in the Nasdaq on Friday October 9th.” — Nasdaq inclusion is a neutral company observation; the anticipated price reaction is not scored.
stocktwits

-0.70 [social_text] “This will drop like a stone” — The post expresses a strongly bearish opinion that Moderna's shares will fall.
stocktwits

+0.00 [news] “Moderna will join the Nasdaq-100 before the open on October 9, replacing Warner Bros. Discovery.” — Moderna's upcoming Nasdaq-100 membership is a neutral index-change observation.
MRNA Stock Soars Ahead Of Slated Return To Nasdaq-100; Retail Echoes Valuation Concerns

+0.40 [social_text] “dont worry bulls. you still "won" today on hopes and some shorts covering.” — The post expresses a bullish opinion that bulls have won the day's action.
stocktwits

+0.00 [social_text] “What a pos.” — The post expresses a negative social reaction to MRNA but provides no company-specific fundamental or attributed opinion to score.
stocktwits

+0.00 [social_text] “MRNA Stock Soars Ahead Of Slated Return To Nasdaq-100” — The item reports MRNA's expected Nasdaq-100 membership change and the associated share-price reaction, which is a neutral observation.
stocktwits

+0.60 [social_text] “get ready bulls” — The post expresses a bullish opinion about MRNA.
stocktwits

-0.60 [social_text] “I will never understand this stock man 💔” — The post expresses strong personal frustration with MRNA without stating a company-specific fundamental or attributed opinion.
stocktwits

+0.00 [news] “outbreak-linked stocks jumped anyway” — The item reports MRNA's share-price reaction to an outbreak event without a scorable fundamental or attributed opinion.
NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards'

+0.00 [social_text] “$MRNA too easy” — The item is a brief, non-substantive observation about MRNA that does not provide a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “Healthcare’s Next Challenge Is Access as MRNA, NVAX and AIDR Expand Their Reach” — The item is a market-wide access discussion that only mentions MRNA as part of a broader group without a company-specific proposition.
stocktwits

+0.00 [social_text] “$MRNA $210 today” — The item reports only MRNA's share price without a substantive fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA +357% in less than a year” — The reported share-price move is a price observation and carries no directional sentiment under the price-blind rule.
stocktwits

+0.00 [social_text] “stocks such as $NVAX and $MRNA just in case...” — The mention is a generic, non-directional suggestion about MRNA without a stated company-specific reason.
stocktwits

+0.00 [social_text] “$SNY next $MRNA ?” — The question is a speculative, non-substantive mention of MRNA without a company-specific proposition.
stocktwits

-0.60 [social_text] “It's nice to look at, but before I touch this, I'd rather go to the casino.” — The author expresses strong reluctance to buy the stock, comparing it unfavorably to gambling.
stocktwits

+0.00 [social_text] “$MRNA ship it!” — The item is a brief, non-substantive call to action that does not state a scorable fundamental or attributed opinion about Moderna.
stocktwits

+0.60 [social_text] “$190 or $230 tomorrow” — The item presents two possible analyst price targets for MRNA, indicating a bullish outlook.
stocktwits

+0.00 [social_text] “Good to hear from you on a different ticker than $CROX.” — The post acknowledges prior MRNA discussion but offers no substantive company-specific sentiment.
stocktwits

+0.00 [social_text] “$MRNA 👀 256%” — The item reports only a share-price move without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA 204.85 res” — The item reports only a price observation for Moderna with no substantive company proposition.
stocktwits

+0.00 [social_text] “$MRNA $NFLX um we can literally figure out each thing you deleted if we actually gave a sh*t lol” — The post is generic social commentary that does not present a substantive proposition about Moderna.
stocktwits

+0.00 [social_text] “$MRNA already has the treatment” — The item states a neutral company fact without a directional treatment outcome or attributed opinion.
stocktwits

+0.00 [social_text] “im in” — The post expresses personal investment intent but provides no company-specific fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “inclusion into the Nas100” — Nasdaq-100 inclusion is a neutral index-membership observation.
stocktwits

+0.00 [social_text] “$MRNA lets fly” — The item reports only a price movement without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “gap up so far” — The item reports only MRNA's share-price movement, which is explicitly neutral.
stocktwits

+0.00 [social_text] “190 or 220 today folks?” — The item only proposes a price target without any supporting fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “Possible triple top.” — A triple top is a technical price pattern and therefore a neutral observation under the price-blind rule.
stocktwits

-0.70 [social_text] “$MRNA rekt again this morning!” — The post expresses a strongly negative attributed opinion about Moderna's recent performance.
stocktwits

+0.00 [social_text] “$MRNA still fighting with 200 $ .” — The item reports MRNA's share price level without a stated fundamental reason or attributed opinion.
stocktwits

+0.00 [news] “Moderna rose 0.17%” — The item reports only a small after-hours price move without a stated fundamental reason.
Moderna, Vaxcyte and Novavax Are Trending After-Hours as Suspected Pneumonic Plague In Russia Stirs Anxiety

+0.00 [social_text] “$MRNA oct 23 $195C” — The item reports only a historical share-price observation with no fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA back to 40” — The item reports only MRNA's share-price level without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$5,000” — The item reports only MRNA's share price without any fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “all of biotech seems to be getting slammed today. Rotation appears to be the call of the day.” — The item describes a broad biotech rotation and does not state a specific fundamental or attributed opinion about Moderna.
stocktwits

+0.00 [social_text] “$MRNA $160?” — The item is a price-level question with no stated fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA nice keep it up bud” — The item is a generic, positive social remark that does not state a scorable fundamental or attributed opinion about Moderna.
stocktwits

+0.00 [social_text] “$MRNA shorts attacked this with vengeance.” — The item describes trading activity and short interest without a stated fundamental reason or attributed opinion about Moderna.
stocktwits

+0.00 [social_text] “will be choppy until 11:45 when Int'l markets settle, but FINISH the day in the GREEN.” — The item is a price prediction without a stated fundamental reason.
stocktwits

-0.70 [social_text] “block all the clowns here immediately” — The post expresses strongly negative sentiment toward MRNA investors.
stocktwits

+0.60 [social_text] “they’ll be more don’t worry 😆” — The post expresses an optimistic, reassuring view about MRNA's future prospects.
stocktwits

+0.00 [social_text] “Thanks for the cheapies!!!!” — The post is a price-blind observation of MRNA's share price without a stated fundamental reason.
stocktwits

+0.00 [social_text] “$MRNA rebalancing much? Whole sector” — The item is a general question about sector rebalancing without a substantive company-specific proposition.
stocktwits

+0.00 [social_text] “this is getting ridiculous. What is causing this BRUTAL SELL OFF?!?!” — The item describes MRNA's reported sell-off without stating a company-specific fundamental reason.
stocktwits

+0.60 [social_text] “$MRNA don’t listen to clowns here” — The post is a one-sided defense of MRNA against a perceived crowd, but it offers no company-specific fundamental or attributed opinion to score.
stocktwits

+0.00 [social_text] “$MRNA buying more i don’t care” — The item records MRNA's investor attention but provides no substantive directional opinion.
stocktwits

+0.00 [social_text] “How criminal is this market” — The item is a general market complaint that does not state a substantive proposition about Moderna.
stocktwits

+0.00 [social_text] “who bought at 211” — The question references MRNA's share price level but provides no fundamental or attributed opinion.
stocktwits

+0.80 [social_text] “$MRNA was $20 Per Share earlier in the Year ... and then it was $200 once the P3 Data hit” — The author's comparison of MRNA's prior share price to a much higher level after data results is an attributed bullish price target thesis.
stocktwits

+0.00 [social_text] “no more 200 now” — The item reports a share-price observation without a scorable fundamental reason.
stocktwits

+0.00 [social_text] “MRNA is around $193–205 today, sitting right near its 52-week high of $208.90 after a monster run — up ~600% in a year, from ~$29 in January.” — The item describes MRNA's price range, proximity to a 52-week high, and annual return; these are price observations and carry no directional sentiment.
stocktwits

-0.60 [social_text] “analysts have all lower PT” — The attributed analyst consensus of lower price targets is a negative forward opinion.
stocktwits

+0.00 [social_text] “$MRNA back to 30” — The item reports only MRNA's share-price level without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “back to your regularly scheduled dump” — The item is a price-blind observation of MRNA's share movement with no scorable fundamental or attributed opinion.
stocktwits

+0.60 [social_text] “make sure you’re considering the 10 day before you see this as a buying opportunity” — The post explicitly frames the period as a buying opportunity, an attributed bullish opinion.
stocktwits

+0.00 [social_text] “$MRNA 300s by EOM” — The item reports a share-price observation without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “above 200” — The item reports MRNA's share price level without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “Maybe we see a run up right before results announcement.” — The anticipated pre-result price move is a price observation, not a scorable fundamental or attributed opinion.
stocktwits

+0.00 [news] “Moderna, Vaxcyte Among The Biggest Losers” — The item reports Moderna's share-price decline without a stated fundamental reason.
Biotech Stocks Tumble, With Recent Winners Moderna, Vaxcyte Among The Biggest Losers

-0.70 [social_text] “I wouldn’t be holding even at 120 by Friday” — The author expresses a bearish forward view on MRNA's share price through a stated unwillingness to hold at a specific level.
stocktwits

+0.00 [social_text] “$MRNA reversal coming by EOD” — The item is only a price-reversal prediction with no stated fundamental reason.
stocktwits

+0.70 [social_text] “Time for reversal to $200+” — The post asserts a bullish reversal target for MRNA.
stocktwits

+0.00 [social_text] “Share Price: $189.89” — The reported share price is a neutral observation and does not constitute directional sentiment.
stocktwits

+0.00 [social_text] “this has been moving in synchrony with $MRNA lately” — The item reports only a price-synchrony observation with no substantive mRNA proposition.
stocktwits

+0.70 [social_text] “people still thinking it’s gonna go down is wild doomed” — The author's strongly bullish opinion that the stock will not fall is a scorable attributed sentiment.
stocktwits

+0.60 [social_text] “Out on puts in on calls.” — The user's stated options transition to a bullish position is a forward-looking attributed opinion.
stocktwits

+0.00 [social_text] “it’s the share requirement being bought up.” — The item reports a share requirement without stating whether it is favorable or unfavorable to Moderna.
stocktwits

+0.00 [social_text] “all bio companies are down” — The item describes a broad sector price move without stating a company-specific fundamental or attributed opinion.
stocktwits

+0.60 [social_text] “That would mean $FIL.X going to $6-$8 ... recapturing 2024 high.” — The author's bullish thesis implies a favorable price target for FIL.
stocktwits

+0.00 [social_text] “this entire sector crash” — The item questions a broad sector move without stating any MRNA-specific fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “unless u in plague stonks like $NVAX $MRNA” — The post identifies MRNA as a traded position but offers no substantive directional opinion.
stocktwits

+0.00 [social_text] “any chance those 237 calls might get in the money this week” — The question is speculative and does not assert a substantive positive or negative proposition about Moderna.
stocktwits

+0.00 [social_text] “all meme's are down today” — The item reports a general market decline without a specific fundamental reason for Moderna.
stocktwits

+0.00 [social_text] “Grabbibg some calls for another move back over $200” — The item is only about a potential share-price move, which is explicitly neutral.
stocktwits

+0.00 [social_text] “$MRNA $9,000” — The item reports only MRNA's share price level without any fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “From $212 to $190” — The item reports only MRNA's share-price decline without a stated fundamental reason.
stocktwits

+0.00 [social_text] “$MRNA printed a new 52-week high today” — A new 52-week high is a price observation and carries no directional sentiment under the price-blind rule.
stocktwits

+0.00 [social_text] “set a new high today and immediately sold off” — The item reports only MRNA's price action without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “we didn’t get a run up like MRNA did… but now we are in sync with their price movement” — The item reports only MRNA's price movement, which is explicitly neutral under the price-blind policy.
stocktwits

+0.00 [social_text] “$MRNA $120 after CPI?” — The item reports a share price level without stating a company-specific fundamental reason.
stocktwits

-0.50 [social_text] “Until it breaks that double top go to the sidelines” — The attributed technical view advises staying out until a specified breakout occurs.
stocktwits

+0.00 [social_text] “This sould be back up to 210 easily” — The item is a price-based expectation without a stated fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “The STAT Summit on October 14–15 could provide an important bridge between Moderna’s Nasdaq-100 inclusion and the full ESMO data.” — The item describes an upcoming event that could refocus attention on Moderna, but contains no scorable fundamental or attributed opinion.
stocktwits

-0.70 [social_text] “BIOTECH PUKE MODE” — The post expresses strongly negative sentiment toward biotech stocks, including MRNA.
stocktwits

+0.00 [social_text] “What a horrible day for biotech.” — The item is a general biotech-day observation without a specific MRNA fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA 182 tomorrow afternoon” — The item is a price-target prediction, but the target itself is a neutral company observation without a stated directional opinion.
stocktwits

+0.00 [social_text] “Moderna traded 6% lower, while Novavax declined by 10%. Despite those declines, Moderna remained more than 130% higher over the past three months, while Novavax was up nearly 20% over that time” — The item reports Moderna's recent share-price move and relative performance without a scorable fundamental reason.
stocktwits

-0.80 [social_text] “This pig is STILL in the trips???? Unbelievable.” — The post expresses strong negative sentiment toward MRNA's investment position.
stocktwits

+0.70 [social_text] “I am still very bullish.” — The author explicitly states a bullish opinion on MRNA.
stocktwits

+0.00 [social_text] “we closed above a heavy resistance area” — The item reports only a technical price observation without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$WMT 107C__+67🔥” — The item reports only a historical share-price move for Walmart, which is explicitly neutral under the price-blind policy.
stocktwits

+0.00 [social_text] “The run up this morning surprised and then the collapse surprised.” — The item describes MRNA's intraday price movement without a scorable fundamental reason.
stocktwits

-0.50 [social_text] “A bearish engulfing candlestick below resistance on the Biotech ETF $IBB suggesting upside exhaustion.” — The described technical pattern is a bearish technical signal for biotech equities, including MRNA.
stocktwits

+0.00 [social_text] “Why did biotechs crash today?” — The item asks about a reported biotech price move without stating any MRNA-specific fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “The shorts pressed hard today so I bought calls.” — The item describes a trader's short-covering activity and position, not a company-specific fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “You mean 219.50?” — The item is only a question about a reported share price and contains no substantive company proposition.
stocktwits

+0.00 [social_text] “$MRNA ok so do something EASY BLOCK” — The post is a generic, non-substantive remark that draws attention to MRNA without a scorable company proposition.
stocktwits

+0.00 [social_text] “$MRNA 5k tomorrow” — The item is a bare prediction of a price move with no stated fundamental or attributed opinion to score.
stocktwits

-0.70 [social_text] “$MRNA cooked” — The slang expression is a strongly negative attributed social opinion about Moderna.
stocktwits

+0.00 [social_text] “@Boring_Kitty reality started to sink in. $MRNA” — The post is a generic, non-substantive observation about Moderna with no scorable company-specific proposition.
stocktwits

+0.00 [social_text] “$187.46 | Strong Uptrend” — The item reports only a bullish price trend and technical indicators, which are neutral observations under the price-blind rule.
stocktwits

+0.70 [social_text] “$MRNA easy $500 this year” — The post expresses a strongly bullish forward price target for Moderna.
stocktwits

+0.00 [social_text] “$187.46 | Strong Uptrend” — The reported price level and uptrend are neutral observations under the price-blind policy.
stocktwits

+0.00 [social_text] “Have you seen the data” — The item is a bare, non-substantive reference to MRNA data without a company-specific proposition.
stocktwits

+0.00 [social_text] “$MRNA wow! Finally” — The item is a bare, contextless exclamation about MRNA that conveys no substantive company proposition.
stocktwits

+0.70 [social_text] “Every 3rd day is a new 52 week high” — The item reports frequent new 52-week highs as bullish momentum.
stocktwits

+0.00 [news] “Shares of Novavax Inc (NASDAQ:NVAX) and Moderna Inc (NASDAQ:MRNA) declined on Wednesday after both companies rose in the previous session following reports of a suspected pneumonic plague case in Russia.” — The item reports Moderna's share-price movement without a scorable fundamental or attributed opinion.
Novavax and Moderna Shares Fall as Citi Assesses Vaccine Sector Volatility

+0.70 [social_text] “it’s going to be a GREAT day!” — The post expresses an explicitly bullish forward opinion about MRNA's day.
stocktwits

+0.00 [social_text] “$MRNA 🫠” — The post is a bare MRNA mention with no substantive company proposition.
stocktwits

+0.60 [social_text] “this has its $BULL type of day” — The post expresses a bullish forward opinion about MRNA's near-term trading day.
stocktwits

+0.80 [social_text] “Give us 220” — The request is a bullish price-target opinion for Moderna.
stocktwits

+0.00 [social_text] “So oversold” — The item characterizes MRNA's price as oversold, which is a neutral technical observation.
stocktwits

+0.00 [social_text] “all the big players have completely disappeared” — The observation describes a change in investor attention without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “this is going back to 180 and then 175 172 169” — The item is a price-level prediction with no stated fundamental or attributed opinion.
stocktwits

-0.40 [social_text] “regret not holding my 187 put” — The investor's stated regret about a put position reflects a bearish view on MRNA.
stocktwits

+0.00 [social_text] “$MRNA Green by open. All biotech recovers today” — The item reports only MRNA's intraday price movement and a general biotech recovery, which is a neutral observation.
stocktwits

+0.00 [social_text] “Daily pump and dump?” — The item speculates about MRNA's short-term price behavior without stating a fundamental reason or attributed opinion.
stocktwits

-0.60 [social_text] “trading 32x earnings” — The author treats the extreme earnings multiple as a liquidity and valuation concern.
stocktwits

+0.00 [social_text] “so they pumped so hard the sell off comes brutal than punp crazy” — The item describes MRNA's reported price move without a scorable fundamental reason.
stocktwits

+0.00 [social_text] “lets break 73 and run” — The item is a price-targeting callout without a stated MRNA fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “why does this keep going up?” — The question is about MRNA's share-price movement, which is a price-blind observation and carries no directional sentiment.
stocktwits

+0.00 [social_text] “this hasnt had consecutive down days of any note” — The item describes MRNA's recent consecutive-day price pattern without a scorable fundamental reason.
stocktwits

+0.00 [social_text] “$MRNA Turning green” — The item reports only a share-price color change without any fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$TEM red to green just like $MRNA” — The item reports only a relative share-price move for Moderna without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA loving this! Greeen!” — The post expresses positive enthusiasm but states no company-specific fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “Was a huge fan for the last year.” — The author's past bullish sentiment is a neutral historical observation without a current MRNA proposition.
stocktwits

+0.00 [social_text] “If you decide to invest money you need to trust yourself, i.e., your judgement.” — This is a general investment-advice proposition that does not bear on Moderna's fundamentals.
stocktwits

+0.00 [social_text] “$MRNA Dolly Parton money” — The post is a bare mention of MRNA without a substantive company proposition.
stocktwits

+0.00 [social_text] “$MRNA buyers defending 185 area. Short 200-205. Cover sub 190” — The item describes only technical support and resistance levels without a scorable fundamental or attributed opinion.
stocktwits

-0.80 [social_text] “keep pumping this POS” — The post expresses strongly negative sentiment toward Moderna.
stocktwits

+0.00 [social_text] “our %gain is higher than $MRNA today” — The item reports MRNA's relative performance as a price observation, which is neutral.
stocktwits

+0.70 [social_text] “Moderna is strong.” — The post makes an explicitly bullish attributed opinion about Moderna's condition.
stocktwits

+0.00 [social_text] “are we going to $1000” — The post is a price-level speculation without a stated fundamental reason or attributed opinion.
stocktwits

-0.70 [social_text] “I wouldn't shoot that in my worrst friends a whole.” — The user's hyperbolic statement expresses a strongly negative opinion about Moderna.
stocktwits

+0.00 [social_text] “headfake” — The item is a bare, target-specific observation of price movement without a stated fundamental reason.
stocktwits

+0.00 [social_text] “the stock is - 0.74%” — The item reports only MRNA's share-price movement, which is explicitly neutral.
stocktwits

-0.60 [social_text] “keep shorting” — The post expresses a bearish sentiment toward MRNA by urging continued shorting.
stocktwits

-0.60 [social_text] “Everyone except for $PSNL shareholders” — The post expresses a strongly negative attributed view that MRNA shareholders are collectively disadvantaged.
stocktwits

-0.70 [social_text] “You’re like some obscure backup player, stuck in the locker room of real life.” — The post expresses a strongly negative attributed opinion about Moderna's market position.
stocktwits

-0.70 [social_text] “I don’t think this will end well for anyone” — The user expresses a strongly negative forward opinion about the outcome for Moderna.
stocktwits

+0.00 [social_text] “$SLS $ABBV $MRNA $GLSI is Lacking.” — The post mentions MRNA only as an incidental ticker without any substantive proposition about Moderna.
stocktwits

+0.40 [social_text] “Thank you bulls.” — The post explicitly thanks bullish participants, indicating bullish social sentiment toward MRNA.
stocktwits

+0.00 [social_text] “fill my 200 short” — The post reports a short-covering action without stating a fundamental reason or attributed opinion about Moderna.
stocktwits

+0.40 [social_text] “the short sellers are getting roasted again” — The post attributes a negative sentiment to short sellers without stating a fundamental reason for that sentiment.
stocktwits

-0.80 [social_text] “$MRNA JUNK” — The post expresses a strongly negative attributed opinion about Moderna.
stocktwits

+0.60 [social_text] “a prop job sponsored by the heavens” — The attributed bullish thesis is the only substantive sentiment about Moderna in this item.
stocktwits

+0.70 [social_text] “we different at $MRNA” — The user's confident bullish claim is explicitly attributed to the individual poster.
stocktwits

+0.70 [social_text] “Charts didn’t lie fella. $MRNA can’t be STOPPED.” — The post expresses a strongly bullish social opinion about Moderna's prospects.
stocktwits

+0.60 [social_text] “$MRNA gtr3rs is arriving next week” — The anticipated arrival of the next-generation vaccine is a positive product-development development.
stocktwits

+0.40 [social_text] “Updated RSV/flu combo vaccine data expected to keep investor attention on the pipeline into year-end.” — Expected updated data on the RSV/flu combination vaccine is a positive attributed catalyst for investor attention on the pipeline.
stocktwits

+0.00 [social_text] “So we pumping vaccine stocks on Monday” — The item reports a price move for vaccine stocks without a company-specific fundamental reason.
stocktwits

+0.00 [social_text] “$MRNA follow $VST” — The post only states a comparison to Vaxcyte without providing any substantive judgment about Moderna.
stocktwits

+0.00 [social_text] “the Imminently Due P3 Results are Announced” — The anticipated P3 results are mentioned but not characterized as positive or negative.
stocktwits

+0.80 [social_text] “Vaxcyte Reports Positive Topline Data from OPUS-1, the Pivotal Adult Phase 3 Trial of VAX-31” — Vaxcyte's positive pivotal Phase 3 trial results are a strong positive development for the company.
stocktwits

-0.80 [social_text] “you really think the higher ups would allow "cure for cancer" drugs for the masses?” — The author attributes a conspiratorial motive to prevent broad access to mRNA therapeutics.
stocktwits

+0.70 [social_text] “MRNA MC jumped $40 Billion in 3 hours after Cancer vaccine data.” — The item attributes a large positive market reaction to mRNA's cancer-vaccine data.
stocktwits

+0.00 [social_text] “$NVAX $MRNA will catch up to $MRNA MC soon.” — The item is a generic comparison between two vaccine companies with no stated directional proposition about Moderna.
stocktwits

-0.70 [social_text] “Maybe they have another fake vaccine for the Russian lab leak incident.” — The attributed speculation casts MRNA's vaccine as disingenuous and linked to a discredited origin theory.
stocktwits

+0.00 [social_text] “$TNXP Gap fill $7.90 and I'll consider it for the cold season..” — The post states a neutral pricing/seasonality observation without a directional company judgment.
stocktwits

-0.60 [social_text] “Once it squeezes off those two headlines that's your TP target.” — The author treats the plague headlines as a temporary demand headwind and identifies a target price once they subside.
stocktwits

-0.40 [social_text] “How come $MRNA doesn't have a pneumonia vaccine yet” — The post treats the absence of a pneumonia vaccine as a negative proposition for Moderna.
stocktwits

+0.00 [social_text] “Potential vaccine for the new Russian plague outbreak?” — The speculative question about a potential vaccine does not establish a concrete positive or negative MRNA proposition.
stocktwits

+0.00 [social_text] “Who has the vaccine for the new Russian possible pandemic?” — The question does not state whether Moderna has a vaccine or provide a directional assessment.
stocktwits

+0.00 [social_text] “this same type of thing happened with other potential diseases” — The item describes a historical pattern of vaccine development without stating a specific direction for Moderna.
stocktwits

-0.60 [social_text] “when plagues are profit” — The item criticizes MRNA's profit motive in pandemic response.
stocktwits

-0.60 [social_text] “first it was China Covid19 and now it’s Russia…. Covid 20?!?!?!” — The post alleges a pattern of politically motivated pandemic manipulation that implicates Moderna.
stocktwits

+0.70 [social_text] “Vaxcyte’s Shot Clears A Late-Stage Test” — Vaxcyte's late-stage test clearance is a positive development for that company, not Moderna.
stocktwits

-0.70 [social_text] “stay the hell away from the US” — The post expresses a strong negative sentiment toward the virus's presence in the United States.
stocktwits

+0.00 [social_text] “Me getting ahead of the new Russian Pneumonic Plague pandemic” — The post is speculative and does not present a substantive proposition about Moderna's fundamentals or prospects.
stocktwits

+0.70 [social_text] “$SLS $MRNA + $50B based on its P3 cancer vaccine results” — The attributed valuation increase is based on a positive result from Moderna's P3 cancer vaccine program.
stocktwits

-0.40 [social_text] “Russia Plague Fears Spread” — The item links Novavax to a spreading plague risk, which is a negative attributed risk proposition.
stocktwits

+0.00 [social_text] “We look at mRNA, vaccine commercialization and telehealth access through $MRNA, $NVAX and $AIRDF” — The item discusses MRNA's business areas without stating a directional company proposition.
stocktwits

-0.80 [social_text] “$MRNA gonna reject 194 like a Mormon broad at a hoedown” — The item presents a strongly negative attributed opinion that MRNA will reject a vaccine approval.
stocktwits

-0.60 [social_text] “to wish for plague.so ur spec bio goes up is horrible.” — The author argues that a return to plague would be beneficial for Moderna's specialty vaccine business, implying the current absence of plague is negative for demand.
stocktwits

-0.70 [social_text] “this entire biotech trade looks sus AF” — The author expresses a strong negative opinion that the biotech trade is suspicious and coordinated.
stocktwits

+0.80 [social_text] “About to explode on plaque vax news” — The item presents an attributed, strongly positive expectation of a plaque vaccine development outcome.
stocktwits

+0.00 [social_text] “where are the making the vaccines?” — The question asks about a manufacturing location but provides no substantive positive or negative company proposition.
stocktwits

+0.80 [social_text] “$MRNA added $50B to Its Market Value - in the Days after its P3 Cancer Vaccine Results were announced” — The author attributes a large market-value increase to the announced Phase 3 cancer vaccine results.
stocktwits

+0.70 [social_text] “especially if the vaccine results are great it’s just a matter of time” — The author presents a strong positive forward expectation that vaccine results will be great.
stocktwits

+0.60 [social_text] “another mRNA bioweapon vaccine” — The post asserts that MRNA will develop another bioweapon vaccine, a positive product-development proposition.
stocktwits

+0.00 [social_text] “$NVAX is the next plandemic coming? $MRNA” — The item is a speculative question about a different company's pipeline; it contains no substantive proposition about Moderna.
stocktwits

+0.70 [social_text] “Best AI pharma play!” — The item is an explicitly favorable attributed investment thesis about Moderna as an AI-focused pharmaceutical opportunity.
stocktwits

+0.00 [social_text] “Make sure you get your 20th booster shot silly.” — The item is a generic, non-company-specific jab at boosters rather than a substantive proposition about Moderna.
stocktwits

+0.70 [social_text] “Gps Phase 3 Registrational Results are Coming ... Now Truly Imminent” — The item presents imminent Phase 3 results for an mRNA cancer vaccine as a strongly positive development.
stocktwits

+0.00 [social_text] “Kennedy Plans Federal Vaccine Injury Initiative” — The proposed initiative is a substantive but directionally neutral company observation.
stocktwits

-0.40 [social_text] “a broad federal effort to investigate reported vaccine injuries” — A broad federal investigation into reported vaccine injuries is a negative attributed policy development for vaccine manufacturers.
stocktwits

+0.00 [social_text] “Updated guidance and respiratory vaccine data readouts keeping sentiment choppy ahead of flu season.” — The item reports updated guidance and data readouts but does not state a directional fundamental outcome for Moderna.
stocktwits

-0.70 [social_text] “Loaded short yesterday” — The user's explicit short position is a bearish attributed opinion on MRNA.
stocktwits

-0.60 [social_text] “Just continue to short it” — The author explicitly advocates continuing to short MRNA, which is a bearish attributed trading opinion.
stocktwits

-0.40 [social_text] “$MRNA shorts bamboozled” — The attributed short thesis is presented as having been misled, which is a negative company-specific proposition.
stocktwits

-0.70 [social_text] “$MRNA shorted the fuck out of this fat bitch at 200” — The post asserts a strongly bearish short thesis on Moderna.
stocktwits

-0.80 [social_text] “scammy games played here” — The social post advances a strongly negative attributed thesis about Moderna's conduct.
stocktwits

+0.00 [social_text] “$MRNA $MRVL $MSFT $TSLA” — The item's only content about Moderna is a bare ticker mention with no substantive proposition.
stocktwits

-0.80 [social_text] “A collapse is not far off” — The post presents an explicit bearish thesis that MRNA is close to a major decline.
stocktwits

-0.80 [social_text] “JaneStreet & Citadel insure you do not see any cent regardless of the direction you choose” — The attributed thesis asserts that MRNA cannot generate profit in either direction.
stocktwits

-0.60 [social_text] “they will use this news to dump tomorrow” — The post advances a bearish attributed thesis that MRNA will exploit the news to sell.
stocktwits

-0.40 [social_text] “$MRNA shorts have really no choice” — The attributed short thesis implies MRNA is constrained and difficult to short.
stocktwits

-0.70 [social_text] “they keep getting wrecked on mrna short” — The user's confident claim that MRNA shorts are repeatedly losing is a negative attributed trading thesis.
stocktwits

-0.70 [social_text] “I can't see the retail crowd buying this crap, so who pumps this trash everyday, and exactly who are they dumping it on?” — The author presents a bearish thesis that retail demand is absent and that the stock is overvalued.
stocktwits

-0.70 [social_text] “Great entry for short” — The post presents a strongly bearish attributed trading thesis for Moderna.
stocktwits

+0.00 [social_text] “$MRNA just went short......” — The item reports a short position but provides no stated fundamental reason or attributed opinion about Moderna.
stocktwits

-0.70 [social_text] “keep shorting this monster and blow up yet another account, dumb fuck!!!” — The post is a hostile attack on a short-seller rather than a substantive fundamental or attributed opinion about Moderna.
stocktwits

+0.00 [social_text] “all the shorts on the board are bleeding out” — The post describes a trading outcome rather than a substantive fundamental proposition about Moderna.
stocktwits

-0.60 [social_text] “the price action only reflects shorts covering .. only reason why its going up” — The attributed thesis that the move is driven solely by short covering is a negative attributed opinion on the sustainability of the rally.
stocktwits

-0.70 [social_text] “I am looking at a huge shorting opportunity here” — The user presents a strong bearish investment thesis for Moderna.
stocktwits

+0.00 [social_text] “$MRNA shorts” — The item mentions short interest but provides no substantive direction or attributed opinion about Moderna.
stocktwits

+0.60 [social_text] “when shorts are all gone that's when you take profits. shorts still here, ride it” — The attributed trading thesis treats remaining short interest as a bullish condition for holding.
stocktwits

-0.70 [social_text] “This is not a bearish tesis but i see this stock as a playground.” — The author's thesis that the stock is speculative and lacks near-term profit is a bearish attributed opinion.
stocktwits

+0.00 [social_text] “how’s the short “average up” thesis going?” — The post questions the performance of a short thesis without stating a directional result.
stocktwits

-0.70 [social_text] “the mega short on this BS” — The post advances a strongly negative attributed opinion about Moderna.
stocktwits

+0.60 [social_text] “the required buying being done throughout the last week since the announcement” — The author presents a bullish technical thesis that recent buying is required and will sustain the stock.
stocktwits

-0.70 [social_text] “Bulls Wishing for a pneumonic plague Just to cash in. Thats worst than shorting a cancer stock.” — The attributed short thesis claims bullish sentiment is opportunistic and harmful to a cancer-focused company.
stocktwits

-0.60 [social_text] “Love shorting this pig at 200+ then covering for 10+ pts” — The user expresses a favorable opinion toward shorting MRNA at the stated price level.
stocktwits

-0.70 [social_text] “This junk just keeps paying me.” — The author's repeated characterization of MRNA as 'junk' that pays short sellers is a strongly negative attributed opinion.
stocktwits

-0.80 [social_text] “the day they will announce detailed results this POS will crash” — The item advances a strongly negative attributed thesis that MRNA's detailed results will cause a crash.
stocktwits

-0.70 [social_text] “watch out for a rug pull here....” — The post warns of a potential sharp, deceptive decline in Moderna's shares.
stocktwits

-0.40 [social_text] “$MRNA licking chops to short again” — The post presents a bearish attributed opinion that MRNA is approaching a short opportunity.
stocktwits

-0.60 [social_text] “perfect short I missed” — The user's statement is a forward-looking short opinion on Moderna.
stocktwits

+0.60 [social_text] “all you shorts are fuel for the squeeze” — The post advances a bullish attributed thesis that short interest will fuel a squeeze.
stocktwits

-0.70 [social_text] “$MRNA looks like a bull trap” — The attributed bearish thesis characterizes MRNA's price action as a deceptive bullish trap.
stocktwits

+0.00 [social_text] “142 days since the 78th event.” — The item reports a neutral milestone in Moderna's event cadence without a directional company judgment.
stocktwits

+0.00 [social_text] “the instant the imminent phase 3 results are announced” — The item anticipates Phase 3 results but provides no stated outcome or directional opinion about them.
stocktwits

+0.00 [social_text] “$IBRX vs $ABCL vs $MRNA” — The comparison lists MRNA alongside other companies without stating a directional proposition about MRNA itself.
stocktwits

+0.60 [social_text] “Phase 3 Results are overdue - and Incoming any day now.” — The author presents the upcoming Phase 3 results as a positive development for MRNA.
stocktwits

+0.00 [social_text] “Phase 3 Results are” — The item begins to discuss Phase 3 results but provides no outcome or directional proposition.
stocktwits

+0.60 [social_text] “I'm still hopeful the data will be impressive enough to validate this rally” — The author expects upcoming data to validate the rally, a positive attributed opinion.
stocktwits

+0.70 [social_text] “Phase 3 Registrational Results will come in at 34 to 44 Months of MOS for CR2/3 Patients.” — The anticipated Phase 3 results show substantially longer remission duration than the current standard of care.
stocktwits

-0.70 [social_text] “they couldn’t make money” — The author states MRNA failed to generate revenue from its vaccine, a negative commercialization outcome.
stocktwits

-0.70 [social_text] “Even the melanoma clinical test is questionable still, all data has not been verified or approved.” — The post asserts that MRNA's melanoma trial data remain unverified and unapproved, casting strong doubt on the trial's credibility.
stocktwits

+0.00 [social_text] “体内（in vivo）CRISPR/Cas9遺伝子編集治療（遺伝性血管性浮腫などのパイプライン）” — The item describes Intellia's in vivo CRISPR platform and pipeline but provides no directional assessment of MRNA.
stocktwits

+0.00 [social_text] “体内（in vivo）CRISPR/Cas9遺伝子編集治療（遺伝性血管性浮腫などのパイプライン）” — The item describes Intellia's in vivo CRISPR platform and pipeline but provides no directional assessment of MRNA.
stocktwits

-0.80 [social_text] “mRNA BAD.” — The item makes an explicit, strongly negative attributed judgment on mRNA technology.
stocktwits

+0.70 [news] “The cancer pipeline gave Moderna's shares a rocket boost.” — The cancer pipeline is presented as a strong positive driver for Moderna.
Why Citi Is Sounding the Alarm on Moderna Stock

+0.70 [social_text] “If an mRNA therapeutic could be developed, perhaps they could’ve saved this transplant kidney.” — The author presents a forward-looking proposition that an mRNA therapy could protect transplant kidneys.
stocktwits

+0.60 [social_text] “other areas of disease such as diabetes, where not only might MRNA be able to help the disease but be able to heal the affected organs to a certain point depending on the severity of the scarring or damage.” — The author presents a forward-looking proposition that MRNA could help treat diabetes and potentially repair organ damage.
stocktwits

+0.00 [social_text] “Imminent Gps Phase 3 Results are Announced” — The item reports an upcoming trial result but provides no stated directional expectation for Moderna.
stocktwits

-0.80 [social_text] “mRNA BAD.” — The post makes an explicit, strongly negative attributed opinion on mRNA therapeutics.
stocktwits

+0.70 [social_text] “Gps - • - Preventing Relapse and extending survival, doing what its done in all 7 Prior Trials Including in 2 Phase 2 Trials for AML Remission Maintenance.” — The item presents multiple positive trial results for Gps as a relapse-prevention and survival-extending treatment.
stocktwits

+0.70 [social_text] “the drug works--” — The item makes a positive attributed claim about the drug's effectiveness.
stocktwits

+0.70 [social_text] “Sellas is on the verge of such an advance.” — Dr. Weber's attributed opinion characterizes Sellas's clinical development as approaching a significant advance.
stocktwits

+0.70 [news] “rosy growth prospects from its combined therapy candidate for treating the most common type of skin cancer” — The combined therapy candidate is presented as having favorable growth prospects.
Moderna (MRNA) Soars 175% in Q3: Can The Stock Keep Running?

+0.70 [social_text] “Phase 3 MOS is right now at least 34 months for CR2/3 Patients and SOC/BAT MOS for CR1 patients is only 24.7” — The stated Phase 3 median overall survival is substantially longer than standard-of-care benchmarks.
stocktwits

+0.00 [social_text] “October 24 melanoma data” — The item identifies an upcoming melanoma data release but provides no stated outcome or directional opinion.
stocktwits

-0.60 [social_text] “it’s not bullish for $MRNA should this actually be an oncology thing” — The attributed view treats a potential oncology direction as unfavorable for Moderna.
stocktwits

+0.00 [news] “Moderna stock has surged nearly 600% this year on a cancer vaccine trial result that almost no one outside the trial has actually seen in full.” — The item reports a historical share-price move and the existence of a trial result without providing the result's outcome or any attributed opinion on it.
Moderna Surges 8% as Full Melanoma Readout Nears; BioNTech Ticks Up, Pfizer Slips

+0.00 [social_text] “the current valuation being driven by cancer expectations” — The item presents a valuation hypothesis about MRNA's cancer expectations but does not affirm or refute it, so it yields no directional sentiment.
stocktwits

+0.80 [social_text] “Interim phase 2 pancreatic cancer data VERY impressive.” — The interim phase 2 data are described as very impressive, indicating a strongly positive clinical result.
stocktwits

-0.70 [social_text] “Adding Venetoclax to Onureg, with 8 different dosing attempts - FAILED in the VIALE-M Phase 3 Trial.” — The VIALE-M Phase 3 trial failure of venetoclax plus azacitidine is a strong negative clinical result.
stocktwits

+0.70 [social_text] “cancer treatment partnership show their potential” — The partnership is presented as evidence of Moderna's potential.
stocktwits

+0.00 [social_text] “Traders are reacting to updated guidance on RSV/flu combo vaccine trial data expected soon.” — The item reports an upcoming trial-data catalyst without stating a directional fundamental outcome.
stocktwits

+0.00 [filings_numeric] “1x 4 (1 insider Form-4 filing)” — A single Form-4 filing is a neutral company observation without a stated directional impact.
filings_numeric filings_mix

+0.00 [social_text] “I don’t understand why people want to short this” — The user's confusion about shorting MRNA is a neutral observation rather than a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA 🚀” — The post is a bare bullish reaction with no stated MRNA fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA would be fun if russia reports there was no plague😅” — The item is a price-blind observation about investor attention to MRNA without a scorable fundamental or attributed opinion.
stocktwits

+0.60 [social_text] “$MRNA never doubt me.” — The user's absolute statement expresses strong confidence in Moderna.
stocktwits

+0.00 [social_text] “look at $mrna” — The post draws attention to Moderna but offers no substantive positive or negative company proposition.
stocktwits

+0.00 [social_text] “$MRNA chasers get pucked” — The post describes MRNA trading activity without stating a directional fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA Noice. However, we are seeing nothing new. Same channel.” — The post is a neutral observation that MRNA is being discussed without a new directional fundamental or attributed opinion.
stocktwits

-0.70 [social_text] “another great place to add to my short” — The named investor expresses a strongly bearish attributed opinion on Moderna.
stocktwits

+0.00 [social_text] “$MRNA you people are crazy lol” — The post is a generic, non-substantive reaction to MRNA that provides no scorable company proposition.
stocktwits

-0.90 [social_text] “I hate everything about this fucking crap” — The post expresses an intensely negative attributed opinion about Moderna.
stocktwits

+0.00 [social_text] “$MRNA sold 180 strike P expiring Oct 9” — The reported options sale is a neutral company observation without a stated directional fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA why hasn’t this crashed? Who tf is still buying?!” — The post questions MRNA's price behavior but states no fundamental or attributed directional opinion.
stocktwits

-0.70 [social_text] “$MRNA liquidity gone” — The social post asserts that MRNA has lost liquidity, a negative attributed liquidity condition.
stocktwits

+0.60 [social_text] “Give us $250+” — The post is a direct request for MRNA shares, indicating bullish investor demand.
stocktwits

+0.00 [social_text] “$MRNA battle royale” — The phrase is a bare, non-substantive mention of MRNA without a scorable company proposition.
stocktwits

+0.00 [social_text] “$MRNA $220 legooo” — The post is a bare price mention with no substantive company proposition.
stocktwits

+0.60 [social_text] “they've got the good stuff apparently” — The post expresses a positive but unelaborated investor opinion about Moderna.
stocktwits

+0.00 [social_text] “$MRNA Power baby, power.” — The post is a generic bullish cheer that does not state a company-specific fundamental or attributed opinion.
stocktwits

+0.60 [social_text] “this is my only hedge if the market crashes” — The user presents MRNA as a defensive hedge against a market crash, a positive attributed investment thesis.
stocktwits

+0.00 [social_text] “Surprised it is hanging in there so well.” — The post expresses a neutral observation about MRNA's recent performance without a stated fundamental reason.
stocktwits

-0.60 [social_text] “only retail left buying this dried up turd” — The attributed bearish thesis that only retail remains buying implies weak institutional demand and a deteriorating investment case.
stocktwits

+0.00 [social_text] “$MRNA iykyk see you tomorrow” — The post is a generic, non-substantive reference to MRNA that conveys no directional company proposition.
stocktwits

+0.00 [social_text] “$ABUS $MRNA is that you?” — The post is a bare mention of MRNA without a substantive company proposition.
stocktwits

-0.40 [social_text] “who’s dumping shares right before the close.” — The post attributes share dumping activity to MRNA investors immediately before close.
stocktwits

+0.00 [social_text] “$MRNA CALLS. TOGI PLAY” — The item is a brief, target-specific mention of MRNA but provides no substantive fundamental or attributed-opinion proposition.
stocktwits

+0.00 [social_text] “Welcome back, Moderna.” — The greeting is a neutral observation of Moderna's return to attention without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_engagement] “peak 24 mentions, best rank 18 over 214 snapshots” — Peak mention count and rank are neutral observations of MRNA's social attention without a directional fundamental or attributed opinion.
apewisdom

+0.40 [social_text] “$MRNA is named as a possible aquirer in this article” — Being named as a possible acquirer is a moderately bullish attributed strategic proposition for Moderna.
stocktwits

+0.00 [social_text] “$MRNA join with WDC STX” — The item reports a storage-related partnership but provides no substantive direction about Moderna.
stocktwits

+0.40 [social_text] “We certainly know what we are doing here.” — The statement expresses confidence in MRNA's direction and execution.
stocktwits

+0.00 [filing_section] “INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES” — The Form 3 is a neutral regulatory filing that does not convey a directional opinion about Moderna.
filing_section 3f8bea9c49ba

+0.40 [social_text] “reaching out to management is absolutely the right move here” — The author presents a forward-looking opinion that management engagement is the appropriate response to perceived undervaluation.
stocktwits

+0.00 [social_text] “It is still early to have the last laugh bro 😊” — The post is a neutral, non-specific observation about timing rather than a scorable MRNA fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA moment of truth (for today) right here” — The item is a price-blind observation of investor attention without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “$MRNA $SLS $ABBV” — The item is a bare mention of MRNA without any company-specific proposition.
stocktwits

-0.60 [social_text] “telling people you don't know nothing about the company” — The post asserts the company lacks knowledge, a negative attributed opinion about MRNA.
stocktwits

-0.80 [social_text] “evil company” — The post expresses a strongly negative attributed opinion about Moderna.
stocktwits

-0.70 [social_text] “They will never cure major diseases as why would they want to cut their customers off their balance sheet?” — The attributed thesis claims MRNA lacks incentive to cure major diseases because doing so would reduce its customer base.
stocktwits

+0.00 [social_text] “$TXG $MRNA $OABI $IOVA gonna pretend today never Happened. Deleting my trading app til next week” — The post is a target-specific expression of investor attention but contains no scorable fundamental or attributed opinion.
stocktwits

-0.40 [social_text] “TAKE SOME OF THOSE PROFITS AND PUT THEM TO WORK IN MCRB(Seres Therapeutics)!” — The author explicitly recommends taking profits from MRNA to invest elsewhere.
stocktwits

-0.90 [social_text] “Death today” — The post asserts that Moderna has died, which is a fatal and unambiguous negative claim.
stocktwits

+0.00 [social_text] “$MRNA patent suit news is 2 days old fyi…” — The item mentions a patent suit but provides no substantive direction or outcome for Moderna.
stocktwits

-0.40 [social_text] “$NVAX $PFE sued in Florida.” — The user's request to show an MRNA lawsuit implies litigation risk, though no specific MRNA suit is stated.
stocktwits

-0.40 [social_text] “recap-of-some-of-the-lawsuits-petitions” — The item points to a recap of lawsuits and petitions involving MRNA, indicating legal risk.
stocktwits

+0.00 [social_text] “And look where the battle is...” — The item alludes to MRNA's competitive position but provides no substantive directional proposition.
stocktwits

+0.00 [social_text] “$MRNA $NVAX” — The post mentions MRNA but contains no substantive proposition about Moderna.
stocktwits

+0.00 [social_text] “$NVAX $MRNA” — The item only names Moderna alongside another company in a market roundup without a substantive Moderna proposition.
stocktwits

-0.40 [social_text] “$MRNA also AI can create its own mrna company x1000 so alot of competition too” — The attributed thesis is that AI could enable substantial new mRNA competition.
stocktwits

-0.60 [news] “and so is the risk of giving it all back” — The source identifies a material risk of losing the realized gains.
Moderna Is Up 545% in 2026: Take Profits Now, or Keep Buying?

-0.40 [social_text] “Gates bioterrorism being exposed by Putin” — The attributed claim that bioterrorism is being exposed is a negative forward proposition about Moderna's involvement.
stocktwits

+0.00 [social_text] “the appeal trial with $MRNA will be on November” — The item only reports a possible trial date without stating any outcome or legal position.
stocktwits

-0.80 [social_text] “Stolen tech” — The author characterizes MRNA's technology as stolen, a strongly negative proprietary/opinion claim.
stocktwits

-0.70 [social_text] “they did not “cure” cancer” — The post disputes a cancer-cure claim, presenting a strongly negative attributed opinion on MRNA's therapeutic success.
stocktwits

+0.60 [news] “positive news rolled in for its cancer vaccine” — The item reports positive news about Moderna's cancer vaccine development.
Is A Cancer Vaccine Coming? Moderna, Merck Boosted By The Buzz

-0.60 [social_text] “the cancer cure is like 30% success” — The attributed success probability for the cancer treatment is explicitly low.
stocktwits

+0.70 [social_text] “Gps Phase 3 Results worth $25B -$50B to Big Pharma” — The item attributes a large positive value range to the anticipated Phase 3 results.
stocktwits

+0.40 [social_text] “Updated RSV and flu/COVID combo vaccine data readouts have investors refocused on the pipeline beyond covid.” — Updated vaccine readouts are presented as a positive development for MRNA's pipeline beyond COVID.
stocktwits

+0.00 [social_text] “await REGAL Phase 3 results” — The item reports Sellass's upcoming trial results as a neutral observation without a stated directional outcome.
stocktwits

+0.80 [social_text] “SLS Share Price will at Least 10x the moment the Imminent Gps Phase 3 Results are Announced.” — The attributed thesis is highly bullish on the anticipated Phase 3 results.
stocktwits

+0.80 [social_text] “Truly Miraculous Survival in this Phase 3 trial of Second/Third AML Remission patients not Eligible for Transplant.” — The item presents exceptionally positive Phase 3 survival results for MRNA's AML trial.
stocktwits

+0.60 [social_text] “Cancers like prostate cancer are historically "cold," meaning they naturally suppress the immune system and don't respond well to immunotherapy drugs like Keytruda.” — The item advances a substantive proposition that Keytruda is ineffective against cold tumors.
stocktwits

+0.40 [social_text] “If Recursion shows up in a SURPASS consortium/award, that could be a serious validation catalyst.” — The item presents Recursion's potential inclusion in SURPASS as a positive validation catalyst.
stocktwits

+0.00 [social_text] “$MRNA moved to JNJ” — The item reports only MRNA's index membership change, which is a neutral company observation.
stocktwits

+0.00 [social_text] “this is going in the Nasdaq 100 Friday premarket” — The item reports a neutral index membership change without a scorable fundamental reason.
stocktwits

+0.00 [social_text] “see CNBC cover these stocks” — The item reports CNBC coverage of MRNA without stating a substantive company-specific proposition.
stocktwits

+0.00 [social_text] “THE INDEX EFFECT?” — The item is a bare question about index membership with no substantive proposition about Moderna.
stocktwits

+0.00 [news] “MRNA's Nasdaq-100 entry” — Nasdaq-100 membership is a neutral index-change observation with no directional fundamental impact.
Moderna's Nasdaq-100 Entry: What Does It Mean for the Stock?

+0.00 [social_text] “tomorrow included in Nasdaq” — Nasdaq inclusion is a neutral company observation with no stated directional impact.
stocktwits

+0.00 [social_text] “add to NASD 100” — The item reports a neutral index membership change without a scorable fundamental reason.
stocktwits

+0.00 [social_text] “added to the nasdaq 100” — The item reports MRNA's index membership change without a substantive directional opinion.
stocktwits

+0.80 [social_text] “I believe Sellas is on the verge of such an advance.” — The author's professional opinion asserts Sellas is close to a major therapeutic advance.
stocktwits

+0.80 [social_text] “I believe Sellas is on the verge of such an advance.” — The author's attributed opinion asserts Sellas is close to a major therapeutic advance.
stocktwits

+0.80 [social_text] “I believe Sellas is on the verge of such an advance.” — The author's attributed opinion asserts Sellas is close to a major advance in cancer immunotherapy.
stocktwits

+0.00 [social_text] “$MRNA join with JNJ” — The item reports a partnership but provides no substantive direction about Moderna.
stocktwits

+0.60 [social_text] “announced an expanded, multi-year collaboration to support the potential commercialization of intismeran autogene” — The expanded multi-year collaboration supports potential commercialization of Moderna's jointly developed therapy.
stocktwits

+0.00 [social_text] “Tempus-Announces-Multi-Year-Collaboration-with-Moderna-and-Merck” — The item reports a multi-year collaboration involving Moderna but provides no substantive direction for Moderna.
stocktwits

+0.40 [news] “Tempus (NASDAQ: TEM) today announced an expanded, multi-year collaboration to support the potential commercialization of intismeran autogene (V940/mRNA-4157)” — The expanded multi-year collaboration supports potential commercialization of a novel therapy, a moderately positive development for Tempus.
Tempus Announces Multi-Year Collaboration with Moderna and Merck

-0.60 [social_text] “Moderna’s recent surge is overextended, and options traders may want to consider a bearish position because the stock’s run has outpaced its fundamentals and technical setup.” — The attributed technical thesis that the run has outpaced fundamentals and setup is a bearish opinion.
stocktwits

+0.00 [social_text] “ATM Machine starts every other day” — The item describes MRNA's trading activity without a substantive fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “considering selling my calls” — The user's consideration to sell a call position is a neutral observation of trading activity, not a scorable opinion on Moderna.
stocktwits

+0.00 [social_text] “BTO $MRNA 220c 10/9 @ 2.52” — The item reports a bullish options trade but provides no underlying fundamental or attributed opinion about Moderna.
stocktwits

+0.00 [social_text] “MACD line is about to go below the 0 line.. while at same time being below the signal line..” — The MACD configuration is a technical observation that carries no stated fundamental direction for Moderna.
stocktwits

+0.00 [social_text] “MACD line below singal line MACD getting close to the 0 line if MACD gets below 0 line...” — The item reports only a technical-chart observation without a stated fundamental or attributed opinion about Moderna.
stocktwits

+0.00 [social_text] “follow the MACD line” — The MACD line is a technical indicator; the item offers no fundamental or attributed opinion about Moderna.
stocktwits

+0.60 [social_text] “$FIL.X has been accumulating in the $1.00-$1.20 range for last 10 days.” — The described accumulation over a sustained range is a positive attributed market activity.
stocktwits

+0.00 [social_text] “The last 48 hours of Trading in the stock has represented everything I've ever taught anybody in 30 years on how to trade.” — The item describes MRNA's recent trading activity without a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “One you can buy pullback all day, high low , higher highs, better chances to make money on Clouds Rides” — The item discusses a general intraday trading setup rather than a substantive proposition about Moderna.
stocktwits

+0.60 [social_text] “it's joining Nasdaq100 which is a huge inclusion” — The item treats the Nasdaq-100 inclusion as a positive development for Moderna.
stocktwits

+0.00 [social_text] “Are the short sellers taking a beating again today?” — The question asks about short-seller performance, which is a price-based observation rather than a scorable fundamental or attributed opinion.
stocktwits

+0.00 [social_text] “CDC DIRECTOR SCHWARTZ SAYS IS VERY CONFIDENT THAT THE THREAT TO THE UNITED STATES IS EXTREMELY LOW AFTER PLAGUE INSTITUTE WORKER'S DEATH IN SIBERIA” — The attributed assessment concerns a general biopreparedness threat, not a specific proposition about Moderna.
stocktwits

+0.00 [social_text] “World Health Organization says it is unable to fully assess the risks from Russia plague reports” — The WHO's inability to fully assess the risk is a neutral observation about the assessment process, not a scorable proposition about Moderna.
stocktwits

-0.80 [social_text] “$MRNA ip 10% from this call - zero credibility” — The attributed view that the company's IP is largely unsupported is strongly negative.
stocktwits

-0.80 [social_text] “No data could ever warrant this valuation.” — The attributed thesis that the valuation is unwarranted is a strongly negative forward opinion.
stocktwits

+0.40 [social_text] “only buyers over 200 were panicking shorts” — The post describes active short-covering by buyers above a price level, which is a bullish short-term technical signal.
stocktwits

+0.60 [social_text] “$MRNA will cover the rest of short at 179.50” — The attributed thesis that MRNA will cover remaining short positions is a moderately bullish forward opinion.
stocktwits

-0.40 [social_text] “Keep the health and biotech selloff coming.” — The item characterizes a continuing sell-off in the healthcare and biotech sectors as negative.
stocktwits

+0.40 [social_text] “please moderna give us some money to short squeeze hs to $300” — Users are explicitly requesting Moderna shares to fuel a short squeeze, indicating bullish social demand.
stocktwits

+0.70 [social_text] “$FIL.X is distributed storage no one individual or corporation controls.” — The item advances a bullish thesis that decentralized distributed storage is a favorable proposition.
stocktwits

-0.70 [social_text] “data is bad” — The post asserts that MRNA's data is poor, a negative quality proposition.
stocktwits

+0.60 [social_text] “the report of 2nd death has been officially denied by Russia” — The official denial of an adverse report is a positive attributed proposition about the company.
stocktwits

+0.60 [social_text] “体内（in vivo）CRISPR/Cas9遺伝子編集治療（遺伝性血管性浮腫などのパイプライン）” — The item describes MRNA's in vivo CRISPR platform as a next-generation gene-editing therapy pipeline.
stocktwits

-0.70 [social_text] “Russian Pneumonic Plague” — The post attributes a severe biological threat to MRNA, indicating strong negative sentiment.
stocktwits

+0.60 [social_text] “New week. New opportunity.” — The author frames the week as a fresh opportunity to invest in MRNA.
stocktwits

+0.60 [social_text] “the company is currently trading at an incredibly compressed trailing P/E ratio of just over 5” — A compressed trailing P/E is presented as a positive valuation observation for Elite Pharmaceuticals.
stocktwits

+0.70 [social_text] “the long-term trajectory shows a business that has successfully scaled its quarterly revenues to over $32 million and turned consistently profitable” — The item reports scaled quarterly revenues and consistent profitability as strong business results.
stocktwits

+0.00 [social_text] “following Modernas rally” — Modernas' rally is a separate biotech price move and does not constitute a scorable Moderna proposition.
stocktwits

+0.80 [social_text] “$SLS $MRNA added 60B market cap on a expensive to produce, custom vaccine” — The item attributes a large market-cap increase to Moderna's vaccine platform.
stocktwits

+0.00 [social_text] “$MRNA Oct 9th incoming” — The item only announces an upcoming date without stating any substantive MRNA proposition.
stocktwits

-0.50 [social_text] “Overplayed expectations.” — The item warns that expectations surrounding MRNA are excessively high.
stocktwits

+0.00 [social_text] “making the world a better place!” — This is a generic, non-operational mission statement without a specific MRNA proposition.
stocktwits

+0.00 [news] “Moderna builds on its COVID-era manufacturing lessons” — The item reports Moderna's manufacturing experience without a directional fundamental conclusion.
CPHI 2026: Moderna builds on its COVID-era manufacturing lessons

+0.00 [social_text] “Intismeran profits are split 50/50 with Merck.” — The 50/50 profit-sharing arrangement is a neutral company fact without a stated directional valuation implication.
stocktwits

+0.00 [social_text] “$MRNA $TEM $CRSP” — The item is a bare mention of multiple companies without any substantive proposition about Moderna.
stocktwits

+0.70 [social_text] “two thing in pipeline…S&P100 Addition tomorrow and October 24-26 Cancer trial results...both looks like in favor of MRNA.” — The author presents the upcoming index addition and trial results as favorable developments for MRNA.
stocktwits

-0.60 [social_text] “professional organizations that we get our practice guidelines from, like the American Diabetes Association & American Pediatric Association have taken tens of millions of dollars” — The attributed claim that guideline-setting organizations accepted large sums is presented as a negative ethical concern.
stocktwits

+0.00 [social_text] “$MRNA relative strenght lets ride” — Relative strength is a reported price-performance observation and carries no directional fundamental sentiment.
stocktwits

-0.60 [social_text] “We’re gonna go after $BULL because it has Chinese ties but fully ignore the Shanghai facility that Moderna has for a disease that trump says they created” — The post asserts Moderna should disregard a vaccine facility Trump claims created the disease, presenting a negative judgment about Moderna's conduct.
stocktwits